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 ABSTRACT 
 
 
 
The number of novel materials for use in biomedical implantation is expanding 
rapidly, increasing the success rates of implant procedures. Nanocellulose is being assessed 
as a sustainable and biocompatible material, offering an alternative to conventional 
polymer or metal designs with the appropriate structure for potential tissue integration. In 
this research, the capacity of cellulose nanofibers to serve as biomedical implants is 
assessed through examination of immune responses of transgenic zebrafish, utilizing bright 
field and confocal fluorescence microscopy. Methods for creating microincisions for the 
implantation of dense cellulose nanofiber shards in the zebrafish model were explored, and 
a surgical protocol was developed, along with an apparatus to aid with the procedure.  
Experiments suggest that nanocellulose implants induce slightly more neutrophil migration 
to the wound site than the injury itself, although more data are required to prove statistical 
significance. Integration of the nanocellulose implants also appeared to occur, although 
low implant retention rate rendered these experiments inconclusive. 
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I. INTRODUCTION 
 
 
 
Fish Tagging Procedures 
The application of physical fish tagging devices is crucial to the advancement of 
fisheries science and studies of fish behavior. These devices can be used for species 
identification and documentation of migratory patterns. Several attachment options are 
available, depending on the intent of study.  These fall into two categories: External, 
which include plastic buttons and discs, metal straps, and plastic or metals rods with 
various anchor methods; and internal, which include microtags, coded wire, and several 
types of tags that utilize sonar and radio frequencies (1).   
Tagging procedures range in difficulty depending on the type and location of 
attachment. External tags that are not self-piercing are usually attached with a punch tool, 
needle, or pliers. Internal tags are more invasive and can be applied through 
microincision, injection, or larger-scale surgical implantation for bigger species of fish. A 
widely implemented internal tag is the passive-integrated transponder (PIT), which is 
suitable for recapture scenarios to collect data of growth rate, activity patterns, and 
distance traveled by the fish from the point of release (2). A PIT consists of a microchip 
encased in glass that can be coded to provide identification of individuals that had been 
tagged and released (1,2). These tags are injected or inserted by incision into muscle or 
the body cavity, then activated by an electromagnetic field from a handheld reader (2). 
Several studies have been conducted on PIT tagging methods to optimize survival 
andretention, including one performed by Baras et. al where it was concluded that 
surgical implantation was more effective than injecting the PIT tags into juvenile tilapia 
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once they had reached the proper size (3). These techniques can be implemented to 
promote the success of other investigations of fish surgeries and tag implantations. 
Medical Implants 
The pool of materials utilized in implantation procedures is constantly expanding 
as new engineering methods evolve and novel substances are created. Myriad variations of 
polymers, alloys, and natural fibers constitute the scope of medical implants.  Several 
considerations must be accounted for when choosing a biological implant material since 
the intended purpose of the implant dictates the material properties required for success.  
Biocompatibility, surface structure, mechanical strength, and biodegradability are some of 
the important factors that must be considered in the design of a medical implant.  
As part of the design process, the inertness of a material should be considered, as 
unexpected reactions to an implant can lead to complications of ranging severity, and could 
even be fatal. Therefore, extensive testing is crucial before it can be concluded that 
introduction into the body will be safe. An inert material is not cytotoxic and can exist 
within normal physiology without inducing a negative chemical or biological reaction. 
Even though largely inert, an implant may be rejected as the body recognizes it as a foreign 
object and attempts to expel it. This can be mitigated by configuring the implant structure 
to promote integration into the area of interest. Each tissue type and material has a 
distinctive surface chemistry that contributes to rejection or assimilation when combined 
(4,5), so a marriage between the properties of both sides must be formed for an implant to 
stay in position. 
If an implant is designed to remain intact for several years, the chosen material must 
withstand degradation caused by biological processes within the body. These include 
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erosion by fluid flow, environmental pH effects, and the level of stress applied to the 
implant during normal wear (4). Mechanical strength and elasticity of a material can 
supplement its durability, especially if the site of implantation is within a highly mobile 
region and is subject to increased force. Reinforcement can be provided through chemical 
and mechanical processes, such as heat-treatment and coating, of materials that prove to be 
biocompatible but are less stable and resilient than is required. This promotes 
customization of implant design for applications in which a stronger, less-biocompatible 
material can be coated with a more inert substance to gain the benefit of both. 
Implants are also used to support tissue repair and can be designed to be 
bioresorbable, where the implant stays in place for a determined amount of time then is 
naturally degraded by the body. This eliminates the need for a separate removal surgery of 
the implant and reduces the risks associated with performing multiple operations on the 
same area (5,6). Implants of this nature aid the healing process by providing a platform that 
tissue cells can adhere to and integrate. As the implant gradually degrades, more cells 
infiltrate the affected area and replace it with native tissue. The shape and structure of an 
implant influence the degradation process: a denser material will take longer to break 
down, and other factors such as crystallinity, thermal history, and chemical composition 
also impact the rate of deterioration (5). 
Nanocellulose 
Technological and scientific advances have led to increased development of 
biomaterials suitable for implantation. The popularization of naturally-sourced materials 
has prompted researchers to explore alternative, more sustainable options. Nanocellulose 
is a readily-available material that has been found to be biologically inert, biodegradable, 
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and resilient.  It is produced by applying chemical and mechanical processes to naturally 
abundant cellulose derived from various forms of life, including plants and algae (7,8).  In 
these processes cellulose is extracted in its original form and its structure manipulated on 
the nanoscale, creating a product with versatile applications determined by its method of 
manufacture.  
Nanocellulose is generally produced in three forms: cellulose nanocrystals (CNC), 
cellulose nanofibers (CNF), and bacterial nanocellulose (BNC). For CNC, chemical 
deconstruction is employed to isolate crystalline cellulose from amorphous regions of 
material, whereas CNF are created by finely grinding and enzymatically treating cellulose 
to create rod-like fibers with varying dimensions dependent on the technique of production 
(9). In contrast to both CNC and CNF, BNC is manufactured in bioreactors containing 
bacteria that synthesize and extrude the nanocellulose (9,10). The latter process is more 
expensive and time consuming, as the correct conditions must be met to ensure the success 
of the bacterial culture for large-scale production. 
This study examines the potential of using dense CNF as a replacement for 
conventional polymer implant materials. Variations in structure including density, 
porosity, and specific shape of implant materials affect tissue integration, therefore 
optimization of these parameters is crucial for the improvement of existing implant 
formats. When suspended in an aqueous solution and then dehydrated, CNF can be fused 
into a solid form, creating a block of material. Containing numerous hydroxyl groups, CNF 
molecules create both intermolecular and intramolecular hydrogen bonds that promote 
cohesion and association (7,10). Due to heterogeneous fiber dimensions, CNF assemble 
into a semi-porous structure during the dehydration process (11), the extent of which is 
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dependent on the moisture content of the material. This porosity can increase cellular 
integration, permitting a more secure implant that remains inert when introduced into 
tissue. 
Microincision Techniques 
 Surgeries on the microscale require precision and are difficult to complete 
successfully, even with the appropriate tools and techniques. Microincisions are performed 
in surgeries where deftness is crucial. Two examples include ocular surgery and 
neurosurgery, where manual skill and technology are merged to maximize precision. 
Common practice in corneal and cataract surgeries is phacoemulsification along with 
microincision, a process that includes an ultrasonic tip with aspiration and irrigation to 
maintain the interior fluids of the eye (12,13). Several techniques have been detailed during 
the quest for optimal accuracy with the fewest detrimental effects on the ocular tissue, and 
conventional instruments have been established despite some variation in gauge (12–15). 
Neurosurgery is similar in this regard and continued advances in research aim to improve 
the intricate operations. 
 Animal models may be subjected to surgeries in which microincisions are made, 
depending on the nature of the research; these may include such areas as dermatology, 
myology, immunology, microdissection, and others. The methods for creating a 
microincision vary with the field of study, but it is common to use a dermal laser or a 
microscalpel fashioned from stainless or carbon steel, titanium, or tungsten. In the work of 
Gerlach, Morales, and Wingert (16), tungsten needles were utilized to aid in the 
implantation of microbeads in embryonic zebrafish. The needles were used to create small 
incisions in which microbeads were inserted with the aid of a whisker/lash tool, resulting 
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in a minimally affected region of tissue. The current project examined the functionality and 
precision of tungsten microscalpels compared to carbon steel microscalpels when creating 
microincisions in the epidermis of the zebrafish. 
The Zebrafish Model 
During recent years, Danio rerio have become widely used in biomedical research 
due to their embryonic transparency and rapid breeding, producing up to 100-400 eggs per 
breeding pair in a week (17). Optical transparency persists until 5 days post-fertilization 
(dpf) in wild-type zebrafish, allowing straightforward examination of developmental 
processes and the intricate physiology of the fish. Zebrafish mirror more closely the 
biological processes of higher-level organisms than simple cultured cells and offer delayed 
nerve development in a more cost-effective animal model. Development of transgenic 
zebrafish lines has greatly improved certain experimentation techniques by permitting the 
evaluation of multiple biological parameters while producing large quantities of 
specimens.  
The zebrafish model has been utilized in epidemiology studies due to distinct 
characteristics of its epidermis compared to that of mammals, most notably that it contains 
robust regenerative properties (17,18). Zebrafish epidermis consists of live cells throughout 
each layer, as opposed to mammalian epidermis, which is covered by a layer of dead cells 
(19).  This contributes to rapid re-epithelialization, a process which has been shown to 
occur within 24 hours in the adult zebrafish (17,18). Richardson, et. al. conducted a study 
to assess the immune response of zebrafish when a tissue wound was inflicted (18). An 
injury was created for the observation of regeneration of epithelial cells and the 
inflammatory response to injury at the site of a large excision in the zebrafish tissue.  The 
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resulting healing process was discovered to follow the same steps as adult mammalian 
wound repair, with the advantage of accelerated progress, an aspect that is beneficial for 
high-throughput studies of cutaneous injury repair.  
Among myriad applications for investigative studies, the zebrafish is also an 
excellent model for the observation of immune responses. This is primarily due to the many 
advantages that zebrafish offer, including rapid development and the presence of both 
innate and adaptive immune responses, where activation of the innate response occurs 
within 30 hours post-fertilization (hpf) (17), and the adaptive response develops between 
4-6 weeks post-fertilization (wpf) (20,21). This period between the two types of responses 
allows extended observation of the intricacies of the innate immune response of the model. 
In a study conducted by Mathias, et. al (22), MPO:GFP zebrafish were utilized to assess 
the in vivo inflammatory response after a wound was inflicted on the tail. High-resolution 
imaging during the immune response captured transgenic neutrophil migration to the site 
of injury starting at 6 hours post-injury (hpi), and evidence of neutrophil chemotaxis from 
the injury site toward the vasculature was shown during the resolution phase of 
inflammation (22). 
During an immune response, neutrophils travel to areas of inflammation to 
phagocytose pathogens and other incidental microorganisms. Additional effects that this 
behavior may impart on the overall immune response are still being studied (23). In the 
case of this particular project, the migration of neutrophils toward the implanted 
nanocellulose was modeled to observe its biocompatibility. As the immune responses of 
zebrafish are in many ways comparable to those of mammals (17), observed cellular 
 8 
behavior in this study is analogous to the potential immune response of other animals or 
humans toward nanocellulose in its solid form. 
Objective 
The main objective of this pilot research project was to utilize the zebrafish animal 
model system to assess the potential of dense CNF for use in medical implants.  Previous 
work does not describe implantation studies of this exact nature, but techniques from 
several areas have been combined to inform this effort. One aspect of the project focuses 
on methods for implanting the novel nanocellulose material into zebrafish to evaluate the 
potential of this material for use in prosthetics in humans, as zebrafish generate similar 
immune responses that can be readily observed (17). This project holds considerable 
potential for the advancement of naturally-sourced implantable biomaterials due to the 
biocompatibility, durability, and availability of nanocellulose. Implantation in zebrafish 
required microincisions to be made and physical modification of the nanocellulose to 
permit insertion. A new approach for creating microincisions in juvenile zebrafish was 
explored.  Since 96 hpf zebrafish are delicate and range only between 3.5-4.0mm in length 
(24), conventional techniques are rendered difficult to implement while maintaining the 
survival of the animal.  After implantation, visualization and quantification of neutrophils 
migrating to the site of implantation and the observation of cellular integration of the CNF 
were conducted. Immune responses and other changes in the condition of surrounding 
tissue were monitored and recorded by bright-field and confocal fluorescence microscopy. 
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II. MATERIALS AND METHODS 
 
 
 
CNF Manipulation and Shaping 
Dense CNF material was graciously provided as a solid block by David 
Holomakoff, Dept. of Chemical and Biological Engineering at the University of Maine, To 
create thin wafers of CNF, two mechanical methods were attempted using the machinery 
in the Mechanical Engineering Technology laboratory at the University of Maine. After 
squaring the CNF block to ensure consistent measurements, the first method utilized a six-
flute high helix carbide end mill with a 1.0in diameter set at 0.025-0.050mm thickness, 
which produced tightly coiled curls of CNF, resembling a spindle shape that ultimately 
proved too large to use as an implant in the zebrafish (Figures 2.1-2.2).  
        
Figure 2.2. Spindles generated with end mill.   Figure 2.2. Spindles generated with end mill 
(~0.05mm thickness)                                (~0.025mm thickness) 
    
Since the intent was to create a ‘flat’ implant, the second method employed the use 
of a hand plane, which was used to successfully shave thin CNF strips from the original 
block (Figures 2.3-2.4). Digital calipers were used to identify strips of the appropriate 
thickness for further manipulation. 
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Figure 2.3. Shavings generated with hand             Figure 2.4. Shavings generated with  
plane (>0.05mm thickness)              hand plane (<0.05mm thickness) 
 
The original aim of the experiment was to compare the extent of inflammation and 
tissue integration exhibited by different shapes of CNF, therefore, the CNF strips were 
initially cut into three different shapes: squares, triangles, and rectangles (Figures 3.1-3.3).  
               
Figure 3.1. Rectangle CNF      Figure 3.2. Triangle  CNF       Figure 3.3. Square CNF 
 
While the experiment was eventually reduced in scope to include only the square implants, 
the method of manufacture was the same among the three configurations. Using a 
stereomicroscope with a black stage as a backdrop (Figure 3.4), the CNF strips were held 
in place with forceps in the non-dominant hand and cut with an angled utility knife in the 
other. Shaping of the CNF was challenging, as the strips would split from the stress of the 
knife coupled with the thinness of the material. The shard would tear prematurely, creating 
inconsistent implant sizes that had to be discarded. It was found that focusing the pressure 
on the blade to create a clean chop produced the best results, rather than slicing the knife 
through the CNF. 
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       Figure 3.4. Complete shaping setup 
 
Nanocellulose is prone to swelling in water due to the same reactive hydrogen 
bonds that dictate the self-associative properties of the material (10). For this reason, it was 
anticipated that the implants would swell in vivo amid the interstitial fluid of the zebrafish. 
To accommodate this, the implant size was reduced to approximately 0.50 x 0.50 x 
0.025mm. An assessment of swelling was conducted by imaging a dry 1.0 x 1.0 x 0.025mm 
square of CNF, then leaving it in a petri dish of water overnight. The square was imaged 
again after removing excess water and the dry and wet dimensions were compared (Figures 
4.1-4.2), showing a slight increase in size after soaking. 
           
Figure 4.1. Dry CNF square, 0.53mm2                Figure 4.2. CNF soaked for 22 hours in  
          deionized water, 0.68mm2 (22% increase in area) 
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Further assessment could utilize a physiological buffer instead of water to represent 
swelling of the shard amidst the interstitial fluid of the fish. This experiment also indicated 
increased fragility in wet CNF, illustrating a potential complication that could arise 
following implantation in the zebrafish. 
Zebrafish Transgenic Lines 
This project utilized four lines of zebrafish: Tg(mpx:EGFP), Tg(fli1a:EGFP), 
Casper crossed with Tg(mpx:EGFP), and Casper crossed with Tg(fli1:EGFP). 
Tg(mpx:EGFP) Danio rerio is a transgenic line of zebrafish that expresses EGFP under 
control of a neutrophil-specific myeloperoxidase promoter, where EGFP with an SV40 
polyadenylation site was inserted at the mpx ATG start site, also termed ‘mpo’ (25). The 
transgenic line, fli1 Danio rerio, expresses EGFP along its vasculature through the use of 
a promoter for  fli1 (Figure 51) (26).  
                      
Figure 5.1. fli1 Danio rerio                                    Figure 5.2. Euthanized Casper Danio rerio, 5 
                                    months old 
 
These transgenic lines are similar to AB-wildtype zebrafish with the exception of the 
expression of fluorescent protein. The Tg(mpx:EGFP) line was developed specifically for 
use in immune response studies by Renshaw, et.al. at the MRC Centre for Developmental 
and Biomedical Genetics, University of Sheffield, Sheffield UK to provide a more efficient 
research method for imaging neutrophil migration (25). The Tg(fli1:EGFP) line was 
dorsal fin 
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developed for observation of blood vessel development in zebrafish by Lawson and 
Weinstein at the Laboratory of Molecular Genetics, NICHD, NIH in Bethesda, Maryland 
(26).  Tg(mpx:EGFP) and Tg(fli1:EGFP) embryos were obtained from adult fish housed 
in the University of Maine zebrafish facility. For the purposes of this document, the 
Tg(mpx:EGFP) and Tg(fli1:EGFP) zebrafish lines are referred to as MPO and fli1, 
respectively. 
Casper (roy;nacre) Danio rerio contain genetic mutations that prevent pigment 
formation, rendering the fish transparent into adulthood (Figure 5.2). This line of zebrafish 
was created through the combined effort of Richard Mark White and Anna Spessa et. al at 
the Dana Farber Cancer Institute, The Children’s Hospital Boston, Massachusetts General 
Hospital and Harvard Medical School in Boston, Massachusetts to enhance the sensitivity 
of imaging of stem cells and transplanted tumor cells in adult fish (27). For the development 
of the Casper transgenic line, two previously discovered zebrafish mutations were 
combined: nacre (nacw2), which are devoid of melanocytes that produce the striped 
appearance in wild-type fish; and roy orbison (roya9), which results in the deficiency of 
iridophores that provide reflective properties to the fish (27).  The result of the cross is a 
line of zebrafish suitable for extensive organ observation in adult zebrafish that was 
formerly limited by pigmentation. The Casper adults utilized in breeding the MPO and fli1 
crosses were also housed in the University of Maine zebrafish facility. 
PTU Administration 
 To ensure tissue transparency throughout the maturation of the MPO and fli1 
zebrafish groups, 1-phenyl 2-thiourea (PTU) was administered prior to development of 
pigmentation in the embryo and then as a continuous treatment thereafter to prevent 
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development of melanophores. Treatment during early embryogenesis is important because 
PTU inhibits the conversion of tyrosine to melanin, a mechanism which effectively blocks 
the formation of pigment but does not eliminate pigment that is already present (28). 
Following the protocol developed by Karlsson, von Hofsten, and Olsson (28), a 75µM PTU 
solution was prepared (Appendix B.1) and introduced to 24 hpf embryos (Appendix B.2), 
where about 200 fertilized eggs had been collected from each transgenic line the day 
before. This protocol was followed until the embryos reached 5 dpf, the age at which the 
yolk sac diminishes and the zebrafish have developed the necessary gut anatomy to eat. At 
this point, all larval fish were transferred to 2.75 liter tanks and daily feeding was initiated.  
Due to the requirement of constant immersion in PTU, the fish could not be kept in 
the flow-through tank system that has been established in the secondary zebrafish facility 
to maintain a steady stream of water promoting oxygenation. To accommodate PTU 
treatment, the flow-through tanks were stoppered and mesh inserts, or ‘baskets’, were 
fabricated to allow the preservation of the fish and efficient daily changes of the solution 
(Appendix B.3). A previous experiment that required an immersion treatment used a series 
of plastic cups with mesh insets to contain the fish within the tanks for easy removal during 
solution changes. This new basket design was implemented instead to optimize the space 
that the zebrafish could traverse within the tank to promote optimum growth.  Like many 
organisms, zebrafish growth is limited by the space in which they are enclosed, determined 
by both the tank volume and the population density of fish within the tank.  To ensure the 
success of this experiment, the goal was to yield the largest zebrafish possible within a two-
month period, which prompted the use of the basket inserts and feeding three-times daily. 
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 It was crucial to change the PTU solution every day to maintain sufficient oxygen 
levels for the survival of the zebrafish, and a protocol was devised to reduce the risk of 
human exposure to the toxic chemical (Appendix B.4). The MPO and fli1 groups were 
maintained in this way until the zebrafish were 11 wpf, and it was concluded that 
populations were too small to continue the experiment using the PTU-treated fish. There 
are several factors that may have contributed to the high mortality during this treatment, 
including the stress on the fish from daily removal from water, or the enhanced growth of 
algae in the uncirculated water. Algal growth occurred very quickly from feed and fecal 
matter collecting in the fibers of the mesh baskets, which were difficult to clean while 
containing zebrafish. It was also challenging to avoid collecting fish when maneuvering 
the siphon or skimmer during tank cleanings because of the transparency of the zebrafish.  
As Casper Danio rerio have become the preferred transparent zebrafish model, 
limited protocols exist describing the administration of PTU, particularly involving 
continuous treatment into adulthood. It is possible that the concentration of PTU used in 
this work, while suitable for short-term experiments, may have had deleterious effects with 
prolonged administration. More testing will be required to confirm this hypothesis. The 
zebrafish salvaged from the PTU-treated MPO and fli1 groups were completely transparent 
(Figures 6.1.-6.2), evidence that the regimen had been effective in its main purpose, 
however the remaining fish also appeared stunted in growth when compared to the Casper 
fish of the same age. This may have been caused by the extended PTU treatment, or 
possibly the reduced frequency of feeding in the fish fed twice daily instead of three times. 
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Figure 6.1. Fli1 Danio rerio (mm) 
   
Figure 6.2. MPO Danio rerio (mm) 
 
Tungsten Microscalpel Sharpening 
 Multiple options for a microincision instrument were considered, including 
commercial microscalpels, hypodermic needles, and sharpened tungsten wire. Tungsten is 
a durable transition metal that can be easily honed to a sharp point using electrolysis. 
Electrolysis is a process in which a current is passed through an electrolyte solution, 
mobilizing reacting materials between the electrode and the solution (29). If a conductive 
metal, such as a tungsten wire, is used as the anode, controlled decomposition can occur as 
electrons are withdrawn from appropriate metal atoms to create cations that dissolve into 
aqueous solutions. In this case, surface layers of the tungsten wire progressively 
decompose on the atomic level to create an acute point. 
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Figure 7.1. Electrolysis setup for tungsten decomposition. Reproduced from Ref [30]. 
 
Following the protocol described by Moore and Kennedy (30), coiled tungsten wire 
of 0.5mm diameter was cut into 10-15cm segments (Appendix B.5). The tip of the wire 
was placed in 1M NaOH and an electric current was applied to initiate electrolysis (Figure 
7.1). The wire was positioned in the solution using several orientations to generate different 
tip shapes. For example, vertical submersion (perpendicular to the surface of the NaOH 
solution) yielded a straight, conical tip by raising the wire out of the solution in increments 
to create a gradual taper (Figures 7.2-7.3). The diameter of the tip could be adjusted by 
varying the length of time that the wire was submerged in the NaOH. A sharpened tip with 
a flat bottom edge was produced by creating a 90° bend in the wire approximately 1cm 
from the end and placing it on the meniscus of the NaOH solution (Figure 7.4). This 
procedure was inspired by the work of Conrad et. al where  detailed studies were conducted 
on the fabrication of tungsten needles (31). When left at the surface of the solution, the 
wire is partially surrounded by the meniscus interface and degraded only where contact is 
established with the solution. To create a conical tip as well, the end of the wire was placed 
at a slight angle so that the furthermost point was submerged just under the surface of the 
meniscus, incorporating the previous effort for a gradual sharpened effect along with the 
flattened bottom edge. 
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Figure 7.2. Vertical submersion  Figure 7.3. Vertical submersion, gradual 
withdrawal 
                   
Figure 7.4. Meniscus, flat edge                Figure 7.5. Meniscus/vertical submersion, 
hook 
 
Several other variations were produced, including a hook-like version in which 
approximately 0.5cm of wire was bent at 90°, then the tip was positioned perpendicular to 
the surface of the NaOH solution and submerged for a greater length of time at a higher 
voltage than before. Near the bend, the angle between the solution interface and the 
tungsten wire was no longer perpendicular, resulting in a short, curved hook after most of 
the submerged wire had been dissolved (Figure 7.5). See Appendix A.7 for a catalog of 
the tungsten needles that were created. 
Surgical Water Supply 
 To provide a constant water supply to the zebrafish and ensure proper oxygenation 
during the operation, an apparatus was constructed out of 80/20 T-slot aluminum, silicone 
tubing, and tube connectors. For a stable structure, the 80/20 aluminum was attached to a 
threaded stage with a 90° corner bracket and ¼ - 20 socket head cap screws (5/8” length). 
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Water was supplied by gravity and initiated by repeatedly adding system water to the 
reservoir of a 60mL syringe affixed to the top of the 80/20 aluminum. The flow of water 
was directed through a 10cm section of 3/32” ID, 5/32” OD silicone tubing, then split 
between two 4cm sections of the same silicone tubing using a plastic Y-connector (Figure 
8.3). Customized plastic connectors were inserted into the outflow end of each 4cm section 
to direct the water flow into successive tubing segments. One of these connectors, labeled 
Connector 2, contained two identical 90° attachments arranged as in Figure 8.4. The other 
connector, Connector 3, contained two of the same 90° attachments as in Connector 2 as 
well as one straight attachment, arranged as in Figure 8.5. Each of these attachments on 
Connectors 2 and 3 was inserted into 35cm sections of 1/32” ID, 3/32” OD Tygon® tubing, 
totaling five separate tubes for the water to flow through.  
            
Figure 8.3. Connector 1                              Figure 8.4. Connector 2 
            
Figure 8.5. Connector 3                         Figure 8.6. Connector 4 
 
At the end of each 35cm section was another customized connector (Figure 8.6) 
that contained a single 90° attachment of a smaller diameter than in Connectors 2 and 3. 
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The system water exited the apparatus through this attachment to be directed onto the gills 
of the zebrafish at a steady rate. These five connectors were distributed evenly around the 
perimeter of an agar petri dish to coincide with the molded impressions (described below) 
and fixed in place with hot glue. The smaller diameter of Connector 4 reduced the 
volumetric flow rate of the water and allowed any overflow in the agar plate to be managed 
quickly with a vacuum aspirator and flask. 
Reverse-Mold Agar Well 
 To establish a platform on which to perform the implantation, a reverse-mold well 
was designed using SolidWORKS, then 3D-printed with polylactic acid (PLA), a cheap 
thermoplastic commonly used for 3D extrusion. The main function of the reverse-mold 
well was to create a run-off system that would provide adequate drainage for the constant 
water supply running over the gills of the fish. As determined with the practice tests using 
10.5 wpf zebrafish, it was extremely challenging to execute an incision because the thin 
layer of water on the epidermis deflected the blade and the fish would slide out of position. 
Therefore, the reverse-mold well was designed to also form a holding cell that would 
minimize displacement of the fish during surgery. The resulting molded piece consisted of 
a gradual protrusion that began at the tail position and increased in prominence as it 
approached the gill region (Fish Placement Zone, Figure 9.4), eventually meeting a 
rectangular projection that jutted away from the main piece at the maximum point (Water 
Drainage Channel and Water Outlet Channel, Figure 9.4). When applied to a moldable 
material, prominence facing down, the result was a sloped impression to draw water away 
from the site of implantation in the tail area. This also prevented overflow by funneling 
incoming water into an exit channel. 
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         Figure 9.4. SolidWORKS rendering of reverse-mold agar well 
 
 Once the reverse mold had been fabricated and several had been printed (Appendix 
A.9), 2% bacteriological agar plates were poured and allowed to partially set. To increase 
the efficiency of the operation, five adult fish were intended to be situated on the agar at 
one time, so five reverse molds were placed in the gelatinous agar with the outflow 
channels facing the middle of the plate (Figures 10.1-10.2). After the agar had set 
completely, the reverse molds were carefully removed using forceps, and a hole was carved 
in the middle of the plate to connect the outflow channels. The pipette tip of a vacuum flask 
was applied by an assistant into the center of the carved portion to remove the water 
collected from all five impressions. 
                
Figure 10.1. Reverse-mold applied            Figure 10.2. Reverse-mold removed 
to agar   
FISH PLACEMENT ZONE 
WATER OUTLET CHANNEL 
WATER DRAINAGE CHANNEL 
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Microincision and Implantation 
Before the operation took place, several practice rounds were conducted to 
determine the most efficient method for performing the procedure. The efficacy of the 
tungsten needles was compared to that of the microscalpels in different mounting 
configurations, using a micromanipulator to aid in the uniformity of the maneuver. 
Microincisions were first practiced on some of the 10.5 wpf Casper crosses with limited 
success. The ease of creating a clean cut was assessed, and it was found that the tungsten 
needles performed better when the procedure was done manually, but the microscalpels 
surpassed the tungsten when paired with the micromanipulator (Figures 11.1-11.4). 
Because uniformity of the incisions was the required to maintain the integrity of the 
experiment, it was decided that the latter setup would be utilized in the succeeding 
operations.  
 
Figure 11.1. Red arrows indicate microincision performed with the vertical submersion, gradual-
withdrawal tungsten needle (under epidermis) 
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Figure 11.2. Red arrow:               Figure 11.3. Red arrow: Angled     Figure 11.4.  Red arrow: 
Tungsten hook  inserted into   tungsten needle lifting flap of          Pocket created by 
dorsal line tissue                   epidermis          micromanipulator and 
      22.5° stab microscalpel 
 
The second day of practice involved implantation and utilized 5 month-old Casper 
fish to provide a larger platform for determining the most efficient method. Using the 
previously established microscalpel/micromanipulator setup, several approaches were 
attempted to create an incision and then insert a square piece of CNF. It was discovered 
that the best technique was to use the vertical adjustment knob on the micromanipulator to 
move the 22.5° carbon steel microscalpel until it punctured the epidermis of the zebrafish 
about 0.5mm deep. Then, instead of producing a horizontal movement to create a large 
incision, the microscalpel was left in place. When the former method was attempted, the 
entire fish was dragged by the blade. By remaining stationary within the fish, the 22.5° 
microscalpel served as a guide to insert the CNF implant using the slightly bent tip of the 
15° carbon steel microscalpel under the epidermis. This process worked well with the older 
Casper fish, and the implant was clearly visible (Figures 11.5-11.6).  
dorsal fin 
dorsal fin dorsal fin 
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Figure 11.5. Red arrow: First implantation  Figure 11.6. Red arrow: Successful insertion of  
attempt using micromanipulator and manual       square CNF implant ventral to the dorsal fin in 
insertion                  5  month- old Casper 
 
The proposed experiment setup consisted of three trials: Incision-only, to serve as 
a negative control for observing natural response to an injury; Glass shard insertion, to 
serve as a positive control for observing the response to a known, inert material; and CNF 
shard insertion for the purpose of this experiment. During the operation, the Casper crosses 
were split evenly into the appropriate trials (Figure 12.3). There were enough fish of each 
line to fall within the 20-30 fish that were desired for each trial, 20 being the final count 
for the MPO crosses and 21 for the fli1 crosses, after the smallest fish were removed.  
 
Figure 12.3. Zebrafish trial groups on standby for operation 
The nanocellulose shards were placed in a small amount of water then autoclaved at 15psi 
at 121°C for 15 minutes, then depressurized and cooled for 30 minutes. After cooling, the 
dorsal fin 
dorsal fin 
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sterilized contents were poured onto a sterile brown paper towel laid over a dish (working 
under a fume hood) to filter the shards from the water. The brown paper towel proved to 
be the easiest surface for removal of the CNF and allowed easy transfer to soak in a solution 
of 95% ethanol while remaining on the paper towel. The microscalpels and other 
instruments were also sterilized in a solution of 95% ethanol, then left to dry under the 
fume hood along with the implants prior to the surgery. The microscalpels and forceps 
were also sterilized in 95% ethanol for 30 seconds between each fish procedure.  
The implantation setup was assembled and the agar plate was put in place (Figures 
12.2, 12.4). Before being positioned on the agar mount, each fish was immersed in a 
solution of 200 mg/liter Tris-buffered tricaine methanesulfonate in deionized water to 
ensure proper anesthetization. Following anesthesia, the procedure described above was 
executed along the dorsal line caudal to the dorsal fin. The incision was intramuscular only, 
rendering the implant completely subcutaneous for three-dimensional cellular integration.  
                  
Figure 12.2. Agar plate/water supply                        Figure 12.4. Total operation setup 
apparatus 
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Postsurgical Monitoring 
Immediately upon completion of the surgery, stress experienced by the fish was 
managed by placing the fish in a tank of egg water to regain consciousness, then gently 
reintroducing the fish to their holding tank to allow acclimatization. The holding tank 
contained a solution of cephalexin (6.6mg/L) and methylene blue (30mg/L) to prevent 
bacterial and fungal infection, respectively, that could interfere with, or alter, the response 
to the implant. The zebrafish were maintained in this antibiotic solution for 3 days post-
operation following the protocol by Fang et. al (32) (Appendix B.6), then returned to 
normal holding conditions. The fish were kept in the same tank setup as the PTU treatment, 
utilizing the mesh baskets for the daily solution change because the flow-through system 
was unsuitable for antibiotic immersion. The negative effects encountered from the PTU 
treatment were not expected to occur due to the shorter duration of containment and lack 
of food buildup, as the fish were too stressed to eat. This was evident from a preliminary 
attempt to introduce food on the second day of antibiotic treatment, eliciting a disinterested 
response from the fish. 
 The physical movement of the fish was observed post-operation for at least 10 
minutes to ensure that normal behavior was restored. If severe distress was evident from 
unusual behavior (i.e. prolonged erratic swimming, persistent color change indicating 
stress, etc.), the affected fish was removed from the experiment and promptly euthanized 
using an overdose of sodium bicarbonate- buffered MS222 (300 mg/L) for a duration of 10 
minutes or until the heart had stopped beating to avoid extended distress. Since the surgical 
procedure was performed only once during the initial portion of the experiment, to prevent 
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deleterious side-effects such as weakened cardiovascular strength, no other analgesics were 
administered after the zebrafish had regained consciousness. 
Imaging 
 Post-surgery brightfield and confocal fluorescence microscopy was conducted on 
the zebrafish using an inverted Olympus IX-81  motorized microscope (33), in conjunction 
with an Olympus FLUOVIEW FV1000 confocal scanning unit and image acquisition 
software. To contain the zebrafish and minimize variation of positioning between fish, a 
fish-shaped barrier was created using waxed yarn (Wikki Stix®, (34)) that adhered to the 
temperature-controlled ITO-coated Delta T-dishes, while allowing water to flow into the 
resulting enclosure (Figure 13.1). The Delta T-dishes were secured in a thermo-stage that 
was used to provide support when placed on the microscope (Figure 13.2). After 3 days 
post-operation, the zebrafish were immobilized with MS-222 (200 mg/liter Tris-buffered 
tricaine methanesulfonate), then collected with a plastic transfer pipet, trimmed to 
accommodate the size of the fish, and laid into the corralled region on the Delta T-dish.  
                            
Figure 13.1. Delta T-dish (0.5mm) with waxed           Figure 13.2. Delta T-dish on stage 
yarn barriers (cm)                                                       adapter for fish (cm)     
 
The duration of the imaging procedure was dependent on the number of layers that 
were scanned. The MPO Casper crosses required a step size of no more than 2.00µm 
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between scan layers for detection of neutrophil cells, taking up to 8 minutes to complete a 
total scan, while the fli1 Casper crosses were imaged with a step size of 5.00µm, taking up 
to 5 minutes (refer to Appendix A.13 for scan settings). The solution in the Delta T-dish 
was changed frequently with a pipet while on the microscope stage. The MS-222 solution 
was replaced with system water near the end of imaging to prevent prolonged exposure, an 
event that seemed to result in death in imaged fish. 
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III. RESULTS 
 
 
 
 Zebrafish Lines Used 
The original intent of this experiment was to cross Casper Danio rerio with MPO 
and fli1 lines to produce transparent juveniles containing the fluorescence properties 
described above. The crossbreeding was performed in the zebrafish facility at the 
University of Maine by the facility manager. At 1.5 wpf it was observed that pigmentation 
was a dominant trait in several crossed individuals from each transgenic line and stripes 
were apparent in the fish. For this reason, administration of PTU was initiated on separate 
groups of MPO and fli1 Danio rerio to remove pigmentation while preserving EGFP 
expression in the neutrophils and vasculature, respectively, of the zebrafish. The Casper 
crosses continued to develop and were raised separately alongside the treated transgenic 
lines in the secondary zebrafish facility, also at the University of Maine.  
Eventually, it became clear that the PTU-treated MPO and fli1 fish were smaller 
in size and number than required for the experiment. The drastic population decline 
coupled with the time constraint of the project led to the termination of the PTU-treated 
groups. The Casper crosses were maintained and utilized for the implantation surgery 
despite visible pigmentation along the zebrafish body (Figures 14.1-14.2). 
Figure 14.1.  Casper / MPO: 3 wpf (left) and 10.5 wpf (right) 
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Figure 14.2.  Casper / fli1: 3 wpf (left) and 10.5 wpf (right) 
 
 
Performing the Surgery 
The main procedure was more arduous than the preceding tests due to the fact that 
the MPO and fli1 Casper crosses were less developed than the 5 month-old fish used for 
practice surgeries. At only 7 wpf, and with mixed sizes ranging from 8 to 16mm, it was 
challenging to follow the same implantation protocol on each fish. Furthermore, the 
glassshard trial did not work because it was impossible to ensure that the clear material had 
been placed sub-epidermally, and the shard was also difficult to manipulate with the 15° 
microscalpel. The use of forceps was also attempted with the same level of success as the 
microscalpel, and the glass trial was discarded. The length of the procedure was dependent 
on the trial: Incision-only lasted about 30 seconds per fish, and CNF implantation required 
up to 2 minutes per fish to complete. Incision size was refined to minimize affected tissue 
and reduce the potential of residual pain by using the technique described for the practice 
tests. No sealant was used on the incision post-implantation as zebrafish skin completely 
re-epithelializes within 24 hours (15), reducing the chance of environmental 
contamination. 
The water supply apparatus worked as predicted; however the length of the 
procedure varied depending on the size of the individual fish, so the intention to complete 
 31 
five zebrafish operations in succession was unreasonable and the multiple tubes were 
unnecessary. The impressions in the agar were also slightly oversized for the smaller 
zebrafish, and though an assistant used vacuum aspiration to help remove excess water, 
slippage of the fish was still occurring and the microscalpel blade was deflected as before. 
A plain poured agar plate and water dripped on the fish with a plastic pipet was 
implemented instead of the large apparatus. This procedure was completed as quickly as 
possible to prevent suffocation of the fish, and the water was applied with a controlled 
effort to avoid the implantation site to minimize blade deflection on the epidermis. 
Post-surgery Survival 
 On average, the fli1-Casper fish were slightly larger than the MPO-Casper fish at 
the time of the surgery. It was hypothesized that this would improve chances of survival, 
however this was not the case, perhaps because the fli1 fish were operated on first and the 
technique was not as consistent. The survival of each trial of zebrafish was assessed 24 
hours after the operation was performed and continuously through the imaging process. 
The day following the procedure resulted in the highest fatalities (Figure 15), specifically 
in the CNF trials. No fish died during the last two days of the post-surgical treatment with 
cephalexin and methylene blue. Once imaging was initiated, it was observed that fatalities 
would occur inconsistently between trials based on the stamina of individual fish during 
the imaging process. After the procedure, the additional exposure to the MS-222 tricaine 
sedative solution often resulted in zebrafish death, which may have indicated that the 
injured fish had developed an intolerance for the MS-222. It is also possible that the fish  
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Figure 15. Post-surgery survival of Casper crosses by transgenic type and surgical trial. Key: 
‘MPO’ denotes MPO-Casper transgenic fish, and ‘Fli1’ denotes fli1-Casper transgenic fish. ‘IN’ 
indicates incision-only trials, and ‘CNF’ indicates the CNF shard trials. 
 
were not adequately oxygenated during the longer image scans and succumbed to the 
oxygen deficiency.  
 These results prompted changes in the procedure to improve survival: The fish were 
left in the MS-222 tricaine solution just until they were anesthetized, then quickly 
transferred to the prepared Delta T-dish with more MS-222 solution dripped over their 
gills, eventually filling the dish. The solution was removed from the dish and replaced with 
system water after each scan and during mid-imaging positioning to increase oxygenation. 
Zebrafish fatalities decreased after these changes were made during imaging, however 
there was a sharp decline in the population after several fish managed to escape their tanks 
through the flow-through outlet into the pipe leading to the filter through which all system 
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water passed. Despite the plastic guards that were placed in the tanks to prevent this from 
happening, a few fish originating from different trials were discovered on the filter, killed 
from suffocation. Thirteen days after the operation, all remaining fli1-Casper CNF 
zebrafish were found to have disappeared from their tank, though there were no fish on the 
filter. The logical explanation was that they had escaped in the manner described above, 
then the filter was cleaned overnight, removing evidence of the event. Imaging ceased 
shortly after for all trials, and the remaining fish thrived with continued maintenance until 
they were euthanized according to the standard protocol (Appendix D) upon conclusion of 
the experiment. 
Postsurgical Trends in fli1-Casper Zebrafish 
As previously stated, the fli1-Casper trials suffered substantial post-surgery 
fatalities, leading to a poor yield of viable data points. In the fli1-Casper incision (fli1-IN) 
trial, 16 out of 21 fish survived, and only 5 out of 21 fish survived in the fli1-Casper CNF 
(fli1-CNF) trial. In general, the fli-1 Casper zebrafish did not present clear expression of 
vasculature to the same extent as the control fli1 zebrafish (Figures 16.1, 16.8), hindering 
assessment of the resulting images from the operation trials. This could have occurred from 
an unanticipated error in the genetic crossing of the fli1 and Casper fish, already evident 
from the presence of pigmentation when the crossed zebrafish should have been 
transparent; it is also possible the crossbred zebrafish may have been hemizygous. 
 34 
                     
Figure 16.1. EGFP on vasculature,                Figure 16.8. fli1-IN: Red arrow indicates re-  
control fish             epithelialized incision at 9 dps                  
 
Imaging of the fli1-IN trial illustrated a lack of expression, indicating additional 
vascularization had occurred (Figures 16.6, 16.10), however disruption of existing 
vasculature was evident in some fish where the incision had crossed the vertebral arteries 
(Figure 16.9). The injuries in this trial re-epithelialized rapidly and localization of 
endothelial cells around the wound diminished with time, suggesting a decline in their 
recruitment to the incision site during the completion of the healing process. 
                            
16.6. fli1-IN: Red arrow indicates some             Figure 16.10.  fli1-IN: Red arrow indicates high 
concentration of endothelial cells, no CNF         concentration of endothelial cells along   
retention; 7dps                                                     vasculature, re-epithelialized incision; 15 dps 
dorsal 
fin 
dorsal 
fin 
dorsal 
fin 
dorsal 
fin 
 35 
 
 
Figure 16.9.  fli1-IN:Red arrow indicates endothelial cells viewed along vasculature, re-
epithelialized  injury with malformed tail; 15dps 
  
 
There was no retention of CNF in the fli1-CNF trial, rendering the affected fish as 
identical to the fli1-IN trial. Most fish from the fli1-CNF trial possessed an empty pocket 
where the CNF had been implanted, and some endothelial cells were evident in the area 
around this region, but definitive vascularization had not developed. Due to the lack of 
CNF, this trial presented no obvious indication of vascularization in the material, therefore 
examination of this portion of the experiment could progress no further. The sudden 
population decline from the escaped fish also contributed to the closure of the fli1-Casper 
trials as there were insufficient numbers of fish to provide a comparison between trials, 
which at that point had consisted of injury (fli1-IN) and even greater injury (fli1-CNF). 
Postsurgical Trends in MPO-Casper Zebrafish 
Though the MPO-Casper trials sustained fewer fatalities than the fli1-Casper trials, 
the number of fish in the MPO-Casper CNF (MPO-CNF) trial was much fewer than 
required to allow determination of statistical significance. From a population of 20 fish, 
only eight survived after surgery, while 19 survived in the MPO-Casper incision (MPO-
IN) trial. In addition, few fish retained the implant in the MPO-CNF trial which further 
dorsal 
fin 
dorsal 
fin 
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reduced the probability of detecting trends in neutrophil migration. Despite the lack of 
statistically relevant data, general observations could be made between the incision and 
implant trials which could help to guide future experiments. 
Heightened concentration of neutrophils was displayed around the region of interest 
in the MPO-IN trial as compared to the same region in the MPO control trial, indicating 
that neutrophil migration was prompted by inflicting an injury (Figures 17.2, 17b.a). A 
distinct increase in the density of neutrophils occurred around the incision site in several 
fish (Figures 17a-17e). It was also observed that the incision had re-epithelialized almost 
completely in most of the imaged fish, and the site of injury was identified by a slight 
absence of pigment.  As imaging did not begin until three days post-operation, the 
occurrence of re-epithelialization during the treatment period was not surprising. There 
appeared to be greater localization of an immune response around the implant site in the 
MPO-CNF trial than in the MPO-IN trial based on a greater presence of bright spots, 
indicating neutrophils. For the fish that did not retain the implant, this could have been due 
to a larger injury being created during the implantation. More practice performing the 
implantation procedure would afford more precision and would help refine the injury area.  
These fish also displayed predominantly re-epithelialized injuries.  
 
 37 
 
 
Figure 17.2. Control MPO: Concentration of neutrophils shown across multiple confocal image 
layers 
 
Figure 17.3. MPO-IN: Neutrophil concentration around site of incision, 4dps 
dorsal 
fin 
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dorsal fin 
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fin 
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Figure 17.4. MPO-CNF: Red arrow indicates   Figure 17.5. MPO-IN: Red arrow 
neutrophil concentration around implantation site;         indicates pigment interruption,  
no CNF retention, 4dps                         neutrophil concentration around the  
           incision site, 8dps  
                            
Figure 17.9. MPO-IN: Red arrow indicates   Figure 17.10. MPO-IN: Red arrow  
concentration of neutrophils around site, 8dps                  indicates greater neutrophil 
concentration in confocal layer superior 
to 17.9                
 
Figure 17.15. MPO-IN: Red arrow indicates re-epithelialized incision and some neutrophil 
concentration remaining along incision site, 14dps 
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Figure 17.13. MPO-CNF: Red arrow points to    Figure 17.14. MPO-CNF: Close-up of  
pocket indicating lack of CNF retention,   17.13; neutrophil concentration is more  
surrounding neutrophil concentration apparent   visible 
 
As previously stated, few zebrafish retained the CNF implant, most likely due to 
improper establishment of the shard during surgery. However, three MPO-CNF zebrafish 
exhibited a small dark spot where the implant had been inserted (Figures 17.6-17.8). The 
CNF shards were difficult to discern from the surrounding tissue upon magnification and 
EGFP was not visible, lending inconclusive evidence of a direct neutrophil response to the 
implant.  
       
Figure 17.6. MPO-CNF: Red         Figure 17.7. MPO-CNF: Red     Figure 17.8. MPO-CNF: Red  
box indicates retained CNF     box indicates retained CNF,        box indicates retained CNF,  
implant, 6dps                  surrounding neutrophil                neutrophil concentration in 
   is present           same plane as CNF implant, 
determined by confocal       
imaging 
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IV. DISCUSSION 
 
 
 
 This project encompassed an array of experiments directed toward the development 
of a novel implantation procedure and involved the design and execution of supplemental 
surgical tools and methods protocols, providing the initial advances of this pilot study. It 
can be concluded that it is achievable to insert CNF shards sub-epidermally in the adult 
zebrafish model and to monitor both implant retention and fish survival while evaluating 
neutrophil migration or vasculature organization using confocal fluorescence imaging in 
pigmented juvenile zebrafish. Furthermore, zebrafish immersion protocols have been 
developed, involving fabrication of a nylon mesh basket to permit exposure to solutes in 
the suspending medium. Construction of a reverse-mold and a water supply apparatus was 
accomplished to support zebrafish survival during surgery,   
 Numerous potential applications for nanocellulose have been identified and many 
have yet to be investigated.  Extension of this pilot project will provide greater insight into 
the biocompatibility of CNF and evaluate its potential as a suitable implant material. 
Whether for use in humans or as a biodegradable fish tagging device, the developed implant 
could contribute to existing technology. Although this study did not to provide conclusive 
evidence regarding immune response and potential for vascularization of CNF shards in 
zebrafish, it serves as a preliminary effort on which to base future studies in the application 
of nanocellulose materials in living systems. 
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V. RECOMMENDATIONS FOR FUTURE WORK 
 
 
 
 Future observation of the implantation of CNF would benefit from utilizing 4-
month or older zebrafish of homogeneous size to increase the chance of subdermal implant 
establishment, as well as fish survival. The technique using the micromanipulator and 
microscalpels can be improved through extensive practice to increase uniformity of the 
injuries between individual fish. To further promote post-surgery survival, the water supply 
apparatus and reverse-mold agar plate should be modified to accommodate both the 
dimensions of the fish and the number of fish that are arranged on the agar and ready for 
operation. The largest issue during surgery was water on the epidermis of the fish deflecting 
the blade of the microscalpel. A method to isolate the operation site could be developed, 
possibly a barricade between the dorsal fin and the gills to direct the water for precise 
oxygenation without compromising the surgery.  
 The imaging procedure would benefit from selecting transgenic zebrafish that 
undergo successful crossbreeding, where the Casper line crossed with the MPO and fli1 
lines yields transparent fish instead of those with pigment, as in this experiment. 
Alternatively, a protocol for long-term PTU administration could be developed, accounting 
for chemical concentration, fish density, and waste removal during maintenance. 
Utilization of more powerful image acquisition and processing software would permit a 
more thorough observation of the vascular and neutrophil behavior in the zebrafish upon 
introduction of CNF, as well as the examination of CNF surface interactions with zebrafish 
tissues and interstitial fluid.  Furthermore, a lower long-term dosage of MS-222 tricaine 
solution may prove necessary to prevent fish fatalities during the imaging process.  
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APPENDIX A: FIGURES 
 
 
 
APPENDIX A.1:  
Block of dehydrated CNF from which the implants were shaved (cm/mm)    
                   
Figure 1.1. Air bubble in block                             Figure 1.2. Detail of fiber formation 
 
Figure 1.3. View of block after squaring 
APPENDIX A.2: 
Shaving the CNF 
        
Figure 2.1. Spindles generated with end      Figure 2.2. Spindles generated with end mill 
mill (~0.05mm thickness)                            (~0.025mm thickness) 
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Figure 2.3. Shavings generated with      Figure 2.4. Shavings generated with hand 
hand plane (>0.05mm thickness)               plane (<0.05mm) thickness) 
APPENDIX A.3: 
Shaping the CNF 
MODIFICATIONS (mm): 
               
Figure 3.1. CNF in              Figure 3.2. CNF in triangle  Figure 3.3. CNF in square 
rectangle form                     form         form 
 
SHAPING SETUP (cm/mm): 
   
Figure 3.4. Angled utility knife                     Figure 3.5. Forceps 
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Figure 3.6. Complete shaping setup 
APPENDIX A.4: 
CNF swelling (mm) 
           
Figure 4.1. Dry CNF square, 0.53mm2        Figure 4.2. Soaked for 22 hours in deionized            
         water, 0.68mm2 (22% increase in area) 
 
APPENDIX A.5: 
Transgenic zebrafish lines 
                   
Figure 5.1. fli1 Danio rerio, 4x         Figure 5.2. Euthanized Casper Danio rerio, 5 
objective           months old 
 
dorsal fin 
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APPENDIX A.6: 
Zebrafish salvaged from PTU treatment - 11 wpf 
 
Figure 6.1. Fli1 Danio rerio (mm) 
   
Figure 6.2. MPO Danio rerio (mm) 
 
APPENDIX A.7: 
 
Figure 7.1. Electrolysis setup. Reproduced from Ref [30]. 
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Tungsten microscalpels created through electrolysis 
                  
Figure 7.2. Vertical submersion Figure 7.3. Vertical submersion, gradual withdrawal  
                   
Figure 7.4. Meniscus, flat edge              Figure 7.5. Meniscus/vertical submersion, hook  
 
         Figure 7.6. Vertical submersion, angled tip 
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APPENDIX A.8: 
Water supply apparatus 
SCHEMATIC: 
 
Figure 8.1. 
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MATERIALS: 
 
Figure 8.2. Silicone tubing (top) and Tygon® tubing (bottom) 
            
Figure 8.3. Connector 1                         Figure 8.4. Connector 2 
            
Figure 8.5. Connector 3                         Figure 8.6. Connector 4 
 
Figure 8.7. 80/20 T-slot aluminum attached to threaded stage with corner bracket, screws 
and nuts 
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APPENDIX A.9: 
Reverse-mold agar well 
SOLIDWORKS RENDERING (mm): 
 
Figure 9.1. BOTTOM VIEW 
 
Figure 9.2. 
 
Figure 9.3. 
WATER  
DRAINAGE 
CHANNEL 
WATER OUTLET CHANNEL 
FISH PLACEMENT ZONE 
WATER OUTLET CHANNEL 
WATER DRAINAGE 
CHANNEL 
FISH PLACEMENT ZONE 
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Figure 9.4. 
3D-PRINTED PART (mm): 
         
Figure 9.5. Bottom view – brim removed      Figure 9.6. Bottom view – brim retained  
 
 
Figure 9.7. Side view – tail end 
 
 
 
FISH PLACEMENT ZONE 
WATER OUTLET CHANNEL 
WATER DRAINAGE CHANNEL 
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APPENDIX A.10: 
Agar plate setup 
                
Figure 10.1. Reverse-mold applied            Figure 10.2. Reverse-mold removed 
to agar   
APPENDIX A.11: 
Microincision practice on euthanized zebrafish 
Red arrows indicate areas of interest, black arrows indicate locations on fish 
 
Figure 11.1. Red arrows indicate microincision performed with the vertical submersion, 
gradual-withdrawal tungsten needle (under epidermis) 
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Figure 11.2. Red arrow:        Figure 11.3. Red arrow:               Figure 11.4.  Red arrow: 
Tungsten hook inserted         Angled tungsten needle lifting       Pocket created by 
into dorsal line tissue            flap of epidermis       micromanipulator and 
         22.5° stab microscalpel 
Implantation practice on euthanized zebrafish 
Red arrows indicate areas of interest, black arrows indicate locations on fish 
  
Figure 11.5. Red arrow: First implantation      Figure 11.6. Red arrow: Successful  
attempt using micromanipulator and manual     insertion of square CNF implant ventral to 
insertion                     the dorsal fin in 5  month- old Casper 
 
 
 
 
 
dorsal fin 
dorsal fin dorsal fin 
dorsal fin 
dorsal fin 
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APPENDIX A.12: 
Operation setup 
COMPONENTS: 
             
Figure 12.1. Micromanipulator                             Figure 12.2. Agar plate/water supply 
       apparatus 
             
Figure 12.3. Zebrafish trial groups on standby for operation       Figure 12.4. Total  
       operation setup 
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Operation setup 
INSTRUMENTS UTILIZED: 
         
Figure 12.5. 22.5° Stab microscalpel               Figure 12.6. 15° Stab microscalpel,  
   slightly bent 
 
        
Figure 12.9. Vetus HRC40 #ESD-15              Figure 12.8. Punctured pipet scooping tool 
tweezers 
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APPENDIX A.13: 
Imaging 
                     
Figure 13.1. Delta T-dish (0.5mm) with waxed           Figure 13.2. Delta T-dish on stage 
yarn barriers (cm)                                                         adapter for fish (cm)     
 
Figure 13.3. Imaging zebrafish using Delta T-dish/stage adapter setup with an Olympus 
IX81confocal microscope 
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Figure 13.4. Olympus FLUOVIEW FV1000 program layout used for image acquisition 
 
APPENDIX A.14: 
Pigmentation of Casper crosses 
 
Figure 14.1.  Casper / MPO: 3 weeks post-fertilization (left) and 10.5 weeks post-
fertilization (right) 
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Figure 14.2.  Casper / fli1: 3 weeks post-fertilization (left) and 10.5 weeks post-
fertilization (right) 
 
APPENDIX A.15: 
 
Figure 15. Post-surgery survival of Casper crosses by transgenic type and surgical trial. 
Key: ‘MPO’ denotes MPO-Casper transgenic fish, and ‘Fli1’ denotes fli1-Casper 
transgenic fish. ‘IN’ indicates incision-only trials, and ‘CNF’ indicates the CNF shard 
trials. 
 
APPENDIX A.16 
Post-surgical trends in fli1 Casper crosses 
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Figure 16.1. EGFP on vasculature (single slice)         Figure 16.2. EGFP on vasculature 
(composite)  
5 days post-surgery  
    
Figure 16.3. fli1-IN: Scattering of epithelial           Figure 16.4. fli1-CNF: Empty pocket  
cells around vasculature, re-epithelialized           indicating lack of CNF retention 
incision 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
dorsal 
fin 
dorsal 
fin 
dorsal 
fin dorsal 
fin 
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7 days post-surgery 
       
16.5. fli1-IN: Very slight EGFP displayed  16.6. Red arrow indicates some  
on vasculature concentration of endothelial cells, no 
CNF retention 
9 days post-surgery  
                                
Figure 16.7. fli1-CNF: No CNF retention,          Figure 16.8. fli1-IN: Red arrow: 
re-epithelialized injury re-epithelialized incision, endothelial 
cells concentrated along vasculature  
 
 
 
 
 
 
 
 
dorsal 
fin 
dorsal 
fin 
dorsal 
fin 
dorsal 
fin 
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15 days post-surgery 
 
Figure 16.9. fli1-IN: Red arrow indicates endothelial cells viewed along vasculature, re-
epithelialized  injury with malformed tail; 15dps 
 
 
Figure 16.10. fli1-IN: Red arrow indicates high concentration of endothelial cells along 
vasculature, re-epithelialized incision 
 
 
Figure 16.11. fli1-IN: High concentration of endothelial cells along vasculature but not 
around site of incision, indicated by red arrow 
dorsal 
fin 
dorsal 
fin 
dorsal 
fin 
dorsal 
fin 
dorsal 
fin 
 66 
 
Figure 16.12. fli1-CNF: Red arrow: No implant retention, high concentration of 
endothelial cells confined to vasculature 
 
 
 
APPENDIX A.17: 
Post-surgical trends in MPO Casper crosses 
Control MPO 
    
   
dorsal 
fin 
dorsal 
fin 
dorsal 
fin 
dorsal 
fin 
dorsal 
fin 
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Figure 17.1. Concentration of neutrophils shown across multiple confocal image layers 
 
  
Figure 17.2. Control MPO: Concentration of neutrophils shown across multiple confocal 
image layers 
4 days post-surgery 
 
Figure 17.3. MPO-IN: Neutrophil concentration around site of incision 
dorsal 
fin 
dorsal 
fin 
dorsal 
fin 
dorsal 
fin 
dorsal fin 
dorsal 
fin 
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Figure 17.4. MPO-CNF: Red arrow indicates neutrophil concentration around 
implantation site; no CNF retention 
6 days post-surgery 
                   
Figure 17.5. MPO-IN: Red arrow indicates     Figure 17.6. MPO- CNF: Box  
pigment interruption, neutrophil concentration          indicates retained CNF implant 
around the incision site 
 
                  
 
Figure 17.7. MPO-CNF: Red box indicates             Figure 17.8. MPO-CNF: Red box 
dorsal 
fin 
dorsal 
fin 
dorsal 
fin 
dorsal fin dorsal fin 
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retained CNF, surrounding neutrophil  indicates retained CNF, neutrophil 
concentration is present      concentration in  same plane as CNF 
implant, determined by confocal  
imaging 
8 days post-surgery  
                                   
Figure 17.9. MPO-IN: Red arrow indicates             Figure 17.10. MPO-IN: Greater 
neutrophil concentration around incision site           neutrophil concentration in 
                                                                                  layer superior to 17d.a  
               
 
Figure 17.11. MPO-CNF: Some neutrophil             Figure 17.12. MPO-CNF: Close-up  
concentration in pocket where CNF              of empty CNF pocket, with  
had fallen out               surrounding neutrophil localization 
14 days post-surgery 
dorsal 
fin 
dorsal 
fin 
dorsal 
fin 
dorsal 
fin 
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Figure 17.13. MPO-CNF: Red arrow points         Figure 17.14. MPO-CNF: Close-up of  
to pocket indicating lack of CNF retention,          17.13; neutrophil concentration is more  
surrounding neutrophil concentration apparent     visible 
 
 
 
Figure 17.15. MPO-IN: Red arrow indicates re-epithelialized incision, some localized 
neutrophils remaining along incision site  
 
 
  
dorsal 
fin 
dorsal 
fin 
dorsal 
fin 
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APPENDIX B: PROTOCOLS 
 
 
 
APPENDIX B.1: 
PTU Preparation 
Safety Measures: PTU:  
Work under hood, wear PPE: gloves, coat, goggles 
1. Add 50mg 1-phenyl 2-thiourea to a 50mL conical tube. 
2. Add 20mL deionized water and vortex for 3 counts of 10 seconds. 
3. Heat tube in water bath, vortexing as above every half hour until dissolved. 
4. Filter through #1 Whatman in funnel or as a filter attachment with a 60mL syringe 
to dispense into larger container. 
5. Bring final volume up to 50mL with deionized water. 
6. Store at 4°C. 
 
APPENDIX B.2: 
Protocol for PTU administration on embryonic zebrafish 
1. Place collected embryos in deep petri dish with 55mL egg water. 
2. Add 0.63mL PTU solution. 
3. Change solution at least once every 24 hours depending on number of embryos in 
each dish. 
APPENDIX B.3: 
Mesh basket assembly 
Materials:   
Nylon mesh 
Sewing machine/thread 
Pins 
Scissors 
Protocol: 
1. Cut nylon mesh into three pieces: one 20” x 4” rectangle, two semicircles with 
radii of 7”. 
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2. Mark the centers, lengthwise, of all three pieces. Use the rounded edge of the 
semicircles and both 20” edges of the rectangle. 
3. Match the center of one edge of the rectangle with the center of one of the 
semicircles; hold together with pins. 
4. Working from the middle, join the curved edge of the semicircle piece with the 
edge of the rectangle and pin. 
5. Sew with a zig-zag stitch with a 1/8”-1/4” allowance (a). 
6. Repeat steps 3-5 with the other semicircle piece to finish basket (b). 
7. Basket should fit into a 2.75L tank. 
      
(a)                                                                  (b)           
 
APPENDIX B.4: 
Protocol for PTU administration in juvenile zebrafish – basket method 
1. Stopper the run-through outlet of a 2.75L tank to prevent leakage (a). 
2. Wearing proper PPE, carefully measure 31.35mL of the PTU solution with a 
graduated cylinder and pipettor; add to tank. 
3. Place tank under system water spout and fill tank three-quarters full with water. 
4. Insert mesh basket and secure with mini binder clips, one by each tank corner (b). 
5. Continue filling tank until water level reaches 1/2” below the rim of the tank. 
6. Add fish and place plastic cover on top of tank (c, d). 
7. If changing solution, fill a clean, empty tank with system water about three-
quarters full. 
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8. Remove basket containing fish from the old solution and quickly place in tank 
from previous step. 
9. Adjust water level if needed to cover the fish, gently rinsing the sides of the 
basket’s interior to release any fish that may have gotten stuck to the mesh during 
transfer. 
10. Bring the old tank to the floor drain and position parallel to the grates, gripping 
the outlet portion. 
11. Stand behind the outlet and raise it to slowly pour the old PTU solution into the 
drain. This helps avoid splashes. 
12. Quickly rinse the emptied tank with deionized water in the sink, then follow steps 
2-5, replacing the mesh basket and fish from step 8. 
13. Empty the extra tank, rinse with deionized water, and spray with perosan. 
14. Dispose of tips in biohazard bag and wipe down all surfaces with perosan. 
 
        
(a)                                                                   (b)        
 
          
(c)                   (d) 
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APPENDIX B.5: 
Electrolytic sharpening of tungsten wire (adapted from Moore and Kennedy ()) 
Materials:  
1M sodium hydroxide (NaOH) in deionized water 
Deionized water 
Tungsten wire (0.5-mm diameter) 
Needle-nose pliers with wire cutter 
Micromanipulator with ring-stand adapter 
Ring stand or similar 
Power supply (regulated direct current of at least 2 amps) 
Electrode (paper clip) 
Mini alligator clips 
Protocol: 
1. Position micromanipulator with ring-stand adapter on stand so that the wire will 
be facing down, providing support if needed. 
2. Cut tungsten wire to desired length, at least 3-5cm, using wire cutters. 
3. Bend the distal 1 cm of the wire to desired angle. 
4. Secure tungsten wire in micromanipulator apparatus (a). 
5. Make 1M NaOH solution with deionized water and put 75mL in a 125mL plastic 
container. 
6. Assemble power supply, electrodes, 125mL container NaOH, mini alligator clips, 
and tungsten wire/micromanipulator apparatus as shown in (b) and (c). 
7. Set power supply between 5 and 20V using direct current (d). 
8. Immerse bent end of tungsten wire using the adjustments on the micromanipulator 
to lower it into the NaOH solution. Watch for bubbles on the electrode after a few 
seconds (e), then continue immersion until tip is <10 µm in diameter. 
9. Rinse tungsten needles with deionized water before use. 
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(a)                                                    (b) 
  
   (c) Reproduced from Ref [30].           (d)       
 
APPENDIX B.6: 
Postsurgical Treatment Protocol 
1. Add 2.3mL methylene blue to 97.7mL deionized water to make 100mL of a 2.3% 
solution. 
2. Carefully break open one cephalexin capsule and weigh out 18.15mg powder into 
a small weigh boat. 
3. Add cephalexin powder and 0.363mL methylene blue to empty holding tanks 
(stoppered). 
4. Insert mesh baskets as in Appendix I, Steps 3-6. 
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5. Administer treatment for 3 days total, changing solution daily by following the 
Appendix I, Steps 7-14 and the steps above. Abstain from feeding fish. 
6. After final treatment, transfer zebrafish to regular run-through tanks and resume 
normal feeding. 
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APPENDIX C: TABLES 
 
 
 
APPENDIX C.1: 
Water supply apparatus 
Flow rate of unclamped tube 
 
TRIAL: TIME (s): WEIGHT (mg): MASS 
RATE(mg/s): 
FLOW 
RATE(mL/s): 
1 60 32.043 0.534 0.534 
2 60 34.980 0.583 0.583 
3 60 33.150 0.553 0.553 
4 60 32.847 0.547 0.547 
5 60 32.979 0.550 0.550 
Average Unclamped: 0.553 0.553 
Table 1.1. Flow rate of unclamped tube 
 
 
 
 
 
 
 78 
Flow rate of clamped tube 
 
TRIAL: TIME (s): WEIGHT (mg): MASS RATE 
(mg/s): 
FLOW RATE 
(mL/s): 
1 60 28.726 0.479 0.479 
2 60 31.129 0.519 0.519 
3 60 30.127 0.502 0.502 
4 60 30.733 0.512 0.512 
5 60 30.680 0.511 0.511 
Average Clamped: 0.505 0.505 
Table 1.2. Flow rate of clamped tube 
 
APPENDIX C.2: 
Water supply apparatus 
MATERIAL SPECIFICATIONS: 
ITEM: DIMENSIONS: QUANTITY: 
80/20 T-slot 
Aluminum 46 x 5 x 2.5 cm 1 
St. Steel 90° Corner 
Bracket 5 x 4.7 cm 1 
socket head cap 
Screws (button 
head) 
¼ -20 UNC x 5/8”  6 
Hex nut ¼ -20 UNC 4 
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Syringe Reservoir 60 mL 1 
Silicone Tubing 3/32"ID x 5/32"OD x 1/32" Wall 
1 x 10 cm 
2 x 4 cm 
Tygon® s3-r306 
Tubing 
1/32"ID x 3/32"OD 
x 1/32" Wall 5 x 35 cm 
Connector 1 (b) 1 
Connector 2 (c) 1 
Connector 3 (d) 1 
connector 4 (e) 5 
Threaded Stage  1 
Table 2. Material specifications 
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APPENDIX D: IACUC PROTOCOL 
 
 
 
APPENDIX D.1: 
IACUC approval notice 
From: Paula Portalatin <paula.portalatin@maine.edu> 
Date: June 21, 2017 at 3:13:16 PM EDT 
To: Paul Millard <paul.millard@maine.edu> 
Subject: Protocol A2017-05-01 - Approval 
Protocol #: A2017-05-01 
Protocol Title: Performing microincisions for the implantation of nanocellulose in the 
juvenile zebrafish model 
PI: Paul Millard 
Species/# Approved: Zebrafish/270 
Approval Period: 6/21/2017-6/20/2020 
 
Dear Paul, 
 
The above referenced protocol has been approved by the University of Maine IACUC. As 
a courtesy the IACUC Office will generally send out reminders for annual and de novo 
reviews however, it is ultimately the responsibility of the PI to ensure that the protocol is 
renewed on time. 
 
All of the proposed methods, procedures, and conditions have been approved AS 
STATED IN THE PROTOCOL APPLICATION. The IACUC must approve any changes 
or deviations from the approved protocol prior to being initiated. 
 
University of Maine Animal Welfare Assurance #:  A3754-01 
The University of Maine is registered as a research facility in accordance with the U.S. 
Department of Agriculture Animal Welfare Act and the Public Health Service Policy on 
the Humane Care and Use of Laboratory Animals. The University of Maine holds the 
Office of Laboratory Animal Welfare (OLAW) of the National Institutes of Health 
assurance for vertebrate animals used in research, teaching and outreach. 
 
The Animal Welfare Assurance (1) confirms the commitment that the University of 
Maine will comply with the PHS Policy, with the Guide for the Care and Use of 
Laboratory Animals, and with the Animal Welfare Regulation; (2) describes the 
institution's program for animal care and use; and (3) designates the institutional official 
responsible for compliance. 
 
I have attached the final approved version to this email. A cage card is also attached; 
please post near or on the cages. Thank you. 
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Sincerely, 
Paula Portalatin, M. Ed., CPIA 
Research Compliance Officer II 
Office of Research & Sponsored Programs 
University of Maine 
Room 402 Corbett Hall 
Orono, Maine 04469-5717 
(207) 581-2657 
 
APPENDIX D.2: 
Completed IACUC protocol 
Version October 2017 
PROTOCOL NUMBER: A2017-05-01 
PI/INSTRUCTOR NAME: Paul Millard 
PROTOCOL TITLE: Performing microincisions for the implantation of 
nanocellulose in the juvenile zebrafish model. 
 
UNIVERSITY OF MAINE 
INSTITUTIONAL ANIMAL CARE AND USE COMMITTEE 
PROTOCOL REVIEW FORM FOR 
RESEARCH, TEACHING OR PILOT STUDIES 
 
This protocol form is for research, teaching, or pilot studies using vertebrate animals.  
Husbandry (breeding and production) of vertebrates solely for the purpose of 
supplying animals for research, teaching or pilot studies requires a different 
documentation form (found on the IACUC website). 
 
GENERAL INSTRUCTIONS:  The Institutional Animal Care and Use Committee 
(IACUC) consists of scientists from several disciplines as well as non-scientists, members 
of the University community, and persons who have no other affiliation with the University 
than as members of the Committee.  The protocol should therefore be described in terms 
understandable by an audience of educated nonspecialists. 
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Please submit the completed protocol to the Institutional Animal Care and Use 
Committee via email to umric@maine.edu.  The form is due TWO weeks prior to a 
scheduled IACUC meeting.  NOTE:  The Principal Investigator (PI) MUST submit the 
protocol.  Another faculty member (no students) may submit the protocol on behalf of the 
PI with documentation of an email exchange that the PI has read and approves.  We require 
this because the PI is ultimately responsible for the content of the protocol submission. 
The meeting dates are posted at: http://www.umaine.edu/research/research-
compliance/institutional-animal-care-and-use-committee-iacuc/meeting-schedule-
and-protocol-due-dates/.  Protocols received late will be held until the next month’s 
meeting.  Please call Gayle Jones (1-1498) or Paula Portalatin (1-2657) if you have 
questions. 
 
The Principal Investigator or Instructor must justify the ethical costs of using live vertebrate 
animals by demonstrating a reasonable expectation that such usage will contribute to the 
advancement of knowledge which may eventually benefit humankind and/or animals.  The 
Principal Investigator or Instructor must further demonstrate that he or she has applied the 
concepts of "alternatives" in designing the protocol.  The term “alternatives” includes three 
components:  replacement (using nonvertebrate animals, cell cultures, tissues from 
slaughter or autopsy, or nonanimal systems); reduction (in the number of animals used); 
and refinement (of design and methods to reduce pain and stress to animals used as well as 
ensuring that the number of animals used is optimal for the analysis proposed). 
 
 
 
1. This form is for New Protocols.  If you wish to amend a previously approved 
protocol, see instructions/form for submitting an amendment. 
 
 
2. Principal Investigator/Instructor and Co-Investigator(s) (NOTE:  The Principal 
Investigator or Instructor must be a faculty member or professional staff): 
 
PI Name: Dr. Paul Millard 
Campus Address: Jenness Hall 
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Phone: 207-735-6037 
Email: hanna.anderson@maine.edu 
 
Co-PI Name: Dr. Con Sullivan 
Campus Address: 284 Hitchner Hall 
Phone: 207-581-2809 
Email: con.sullivan@maine.edu 
 
Will any non-UMaine personnel handle or have responsibilities for the animals (i.e., 
collaborations)?   No  Yes.  If yes, please name personnel below with his/her 
affiliation.  An Inter-Institutional Agreement may be required.  See: 
https://umaine.edu/research/resource/inter-institutional-agreement/ 
 
3. Title of project: 
 
Performing microincisions for the implantation of nanocellulose in the 
juvenile zebrafish model. 
 
4. Date protocol or amendment will go into effect: 
(REMINDER:  Activities may not begin until IACUC approval and amendments 
are only for period of original protocol.) 
May 2017 
 
5. Funding agency for project, if applicable: 
Please attach the vertebrate animal (VA) section/methods section from the 
proposal. If multiple agencies are involved, please send only the VA sections that 
specifically relate to this protocol. 
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N/A 
 
6. Briefly describe the (check appropriate category)  research,  teaching, or  
pilot study objectives (not procedures) that involve use of animals.  Describe these 
objectives in non-technical language.  Do not paste in sections of grant proposals. 
 
The main objective of this research project is to utilize the zebrafish animal model 
system to assess biomaterials with potential for use in medical implants.  The biomaterial 
in question is dense nanocellulose, specifically cellular nanofibrils (CNFs), in solid form 
created in the Chemical and Biological Engineering Department facilities at the University 
of Maine. One aspect of the project will focus on methods for implanting the novel 
nanocellulose material into zebrafish to evaluate the potential of this material for use in 
prosthetics in humans, as zebrafish contain a similar immune response that can be readily 
observed.(17) This project holds considerable potential for the advancement of naturally-
sourced implantable biomaterials due to the biocompatibility, durability, and availability 
of nanocellulose. With a porous composition, nanocellulose enables ample cellular 
integration, permitting a more secure implant. Variations in structure, including the density 
and specific shape of the nanocellulose shard, affect the integration into tissues, therefore 
optimization of these parameters is crucial for the improvement of existing implant 
formats. Implantation will likely require micro-incisions to be made on the model, and/or 
physical modification of the nanocellulose to permit insertion. A new approach for creating 
micro-incisions in the zebrafish may need to be developed, as zebrafish are delicate and 
are only a few millimeters in length, rendering conventional techniques difficult to 
implement while maintaining the survival of the animal. 
When implantation has been accomplished, immune responses and other changes 
in the condition of surrounding tissue will be monitored and recorded by imaging, 
including bright-field and fluorescence microscopy.  MPO zebrafish (GFP-tagged 
neutrophils) will be utilized for the visualization and quantification of neutrophils 
migrating to the site of implantation. The amount of neutrophils that migrate will indicate 
whether the nanocellulose has been rejected or accepted by the model, providing insight 
into whether it remains inert when introduced to tissue. The observation of cellular 
integration of the nanocellulose in the model will also be conducted through the use of fli1 
zebrafish (GFP-labeled vasculature), as well as the microscopy methods listed above. 
 
7. Describe how this use of animals contributes to the advancement of knowledge that 
may eventually benefit humankind and/or animals 
During recent years, zebrafish have become widely implemented in biomedical 
research concerning immunological responses. This is primarily due to the many 
advantages that Danio rerio offer, such as rapid development and the presence of both 
 85 
innate and adaptive immune responses, where activation of the innate response occurs 
within 30hpf,(17) and the adaptive response develops between 4-6 weeks post-
fertilization.(20) This time period between the two types of responses allows extended 
observation of the intricacies of the innate response of the model. In this experiment, the 
implantation will be performed after 96hpf for an initial observation of innate response by 
imaging the neutrophil migration to the implantation site with fluorescence microscopy on 
MPO zebrafish, which express GFP on their neutrophils. Fluorescence microscopy will 
also be conducted on fli1 zebrafish, which express GFP throughout their vasculature, to 
assess integration of the implant into the tissue.(25,26)  
Neutrophils travel to areas of inflammation in order to phagocytose pathogens or 
microorganisms, and additional effects that their behavior may impart on the overall 
immune response are still being studied.(23) In this case, the migration of neutrophils 
towards the implanted nanocellulose will be modeled, including their interaction with the 
implant material, to observe its biocompatibility. As the immune responses of zebrafish 
have been compared to those of mammals, any observed behavior in this study may be 
applied to the potential immune response of other animals/humans towards nanocellulose 
in its solid form.(17) As described in Question 6, nanocellulose is a readily-available, 
naturally-sourced material that is paving the way as a sustainable biomaterial alternative 
that can be optimized for specific biomedical applications, particularly as a replacement 
for conventional polymer materials.(7) 
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8. Total Animals and Pain Classification:   Tabulate the total number of animals per 
species, life stage (e.g., larval, adult, all) and USDA pain classification. Indicate if 
these individuals are genetically modified (e.g., knock-out or transgenic).  
Individuals should be accounted for only once, under the highest pain classification 
planned for their use (see Appendix 1 for classification definitions and examples).  
Breeding and maintenance colonies used to produce or hold study subjects are 
generally not included in these numbers, unless this protocol requires significant 
deviations from approved husbandry practices (see husbandry protocol for 
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associated colony).  Any future increases to these numbers require an approved 
amendment.  (NOTE:  to add rows, right-click within table, click on “insert” and 
choose “insert rows above” or “insert rows below”) 
 
Species 
(Scientific Name/Common 
Name) 
 
Stage(s) USDA  Class 
(B, C, D or E) 
GMO (Y/N) 3 Year 
Total 
  
Danio rerio/zebrafish: MPO 
(GFP-tagged neutrophils) 
Juvenile 
(1.5-2 
months pf) 
C Y 30 
Danio rerio/zebrafish: MPO 
(GFP-tagged neutrophils) 
Juvenile 
(1.5-2 
months pf) 
D Y 90 
 
Danio rerio/zebrafish: TG 
(fli1:EGFP) 
 
Juvenile 
(1.5-2 
months pf) 
D Y 150 
PROJECT TOTAL: 270 
 
Mandatory Requirements for Classification D or E: 
 
a) Veterinary Consultation: A consultation is required before the protocol will be 
formally considered for review.  Please email or phone Dr. James Weber (1-2774, 
jaweber@maine.edu) with a description of the proposed procedures. 
 
Date of veterinary consult: 4/16/17 
 
b) Search for Alternatives: Federal law requires that the PI conduct a documented 
search for alternatives to these procedures.  This includes a written narrative 
describing the written and electronic sources surveyed to identify potential 
alternatives to painful procedures.  Complete the required form at the end of this 
document. 
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9.   State the rationale for use of this/these species and life stages.  Address the issue of 
replacement by explaining why educational or research objectives cannot be met 
by the use of nonvertebrate animals, cell or tissue cultures, or non-animal systems.  
(Please note:  the IACUC does not consider "hands-on experience" to be in and of 
itself an adequate educational objective, unless the course serves students whose 
anticipated educational and professional futures will require the skills imparted 
through such hands-on experience.  If that is true in this instance, please describe 
the student population that typically enrolls in the course.) 
 
MPO and fli1 Danio rerio are the optimal models for this experiment due 
to the ease of observation that they allow because of their embryonic transparency, 
as well as the fact that they provide more complex biological phenomena that more 
closely resemble those of higher-level organisms than simple cultured cells. The 
use of later-stage larval and juvenile zebrafish is required to prevent unnecessary 
embryo fatalities due to the reduced stamina and overall physiological weakness of 
96 hpf and younger zebrafish as compared to older fish. Though the innate immune 
response of zebrafish activates around 30hpf, this experiment will only focus on the 
observation of 96hpf and older fish because the procedure will be more easily 
conducted due to the relative size of the model to the implant. Furthermore, the 
developmental period for the adaptive immune response of zebrafish can range 
between 4-6 weeks post-fertilization, as described in Question 7, therefore older 
fish are required for the observation of these interactions. The MPO zebrafish are 
suitable due to the fact that their neutrophils express GFP, allowing quantification 
of immune response based on the observation of neutrophil migration. The fli1 
zebrafish express GFP throughout their vasculature, providing a quantifiable 
method for observing implant integration into the host. 
 
10.  Justify the number of animals with respect to your overall project design: 
 
a. Study Groups (e.g., treatments and replicates):  Briefly outline the specific groups or 
treatment types that comprise your project. Describe the role each of these groups 
performs with respect to your specific project objectives/hypotheses (e.g., control or 
comparison to another treatment). Indicate whether and how these groups would be 
replicated. 
 
The Class C treatment will consist of juvenile zebrafish that will be euthanized 
immediately prior to microincision and implantation practice.  As this is a pilot study, this 
treatment will provide a platform for assessing the most effective procedure through which 
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to proceed when conducting microincisions and implantation, including the possibility of 
injecting the nanocellulose instead. This treatment will also allow practice for the 
consistency of both procedures and the respective imaging techniques involved to ensure 
uniformity between replicates of the main experiment. 
 
Class C Treatment: Number of Replicates: Number of Zebrafish: 
Euthanasia 30 30 
TOTAL: 30 30 
 
 
There will be 8 treatment groups under the Class D specification: 
Treatment 1: Negative Control, incision (MPO) 
Treatment 2: Negative Control, incision (fli1) 
Treatment 3: Positive Control, implantation of glass (MPO) 
Treatment 4: Positive Control, implantation of glass (fli1) 
Treatment 5: Nanocellulose Shard Shape 1 (MPO) 
Treatment 6: Nanocellulose Shard Shape 1 (fli1) 
Treatment 7: Nanocellulose Shard Shape 2 (fli1) 
Treatment 8: Nanocellulose Shard Shape 3 (fli1) 
 
Each treatment will contain 30 replicates, where 1 replicate = 1 fish, and a single 
shard of the indicated material and shape will be implanted in each replicate. 270 fish will 
be required for the project. This setup will provide insight into the relationship between the 
structure of the implant and the cellular integration of the nanocellulose into the tissue of 
the zebrafish. It will also permit the observation of the effect implant shape may have upon 
the immune response to the nanocellulose, and may indicate physiological preferences such 
as porosity for an optimized implant structure. The CNFs that will be utilized are produced 
with an initial chemical or enzymatic treatment, then mechanically dissociated to create 
homogenous fibrils. The fibrils are reformed by adding a water solution and then 
evaporating the excess to form specific densities of material. Within the University of 
Maine, experiments have previously been conducted with cellular co-cultures to assess any 
potential residual toxicity the nanocellulose may contain from the initial production step. 
 92 
Therefore, a similar assay will be performed prior to implantation to ensure no toxic 
components remain. According to an article by Ning Lin and Alain Dufresne, CNFs have 
not shown any cytotoxicity or proneness to inflammation in studies on mouse or human 
macrophages.(9) 
The density of the nanocellulose that will be utilized is approximately 1.063g/cm3, 
only 6.3% more dense than that of water, and the glass shard contains a density of 
2.4mg/cm3. Therefore, the proposed implants will impart a negligible effect on the ability 
of the zebrafish to swim. The estimated implant dimensions are: 2.0mm length, 0.025mm 
depth, and 1.0mm width, with a mass of approximately 53.2µg for the nanocellulose. The 
glass shard will be formed so that it is comparable in size to the nanocellulose.  According 
to growth studies performed by Hachicho, et.al. and Avella, et.al., the mean wet weight of 
a 6dpf zebrafish is about 0.4mg, and the mean dry weight of a 96hpf zebrafish is about 
70µg.(35,36) As the proposed procedure will be performed on zebrafish 96hpf or later, the 
nanocellulose implant will be about 76% of its dry weight at 96hpf, and about 13.3% of its 
wet weight at 6dpf, using the estimates mentioned above. In observation of these ratios, 
assuming a wet weight value is much more realistic, and allowing a longer development 
period prior to implantation decreases any negative effects the shard may exert on the 
behavior of the zebrafish. After implantation, it is expected that the pores of the 
nanocellulose will be permeated by cellular integration or the extracellular fluid of the fish. 
 
 
Class D Treatments: Number of Replicates: Number of fli1 Zebrafish: 
Incision Only 30 30 
Glass Shard 30 30 
Nanocellulose Shard, Shape 
1 
30 30 
Nanocellulose Shard, Shape 
2 
30 30 
Nanocellulose Shard, Shape 
3 
30 30 
TOTAL: 150 150 
 
Class D Treatments: Number of Replicates: Number of MPO 
Zebrafish: 
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Incision Only 30 30 
Glass Shard 30 30 
Nanocellulose Shard, Shape 
1 
30 30 
TOTAL: 90 90 
 
a.  Sample Sizes:  Provide a rationale for the number of individuals (per study group or 
replicate) based on the specific inferential methods to be used.   Address the issue of 
reduction by explaining why the proposed number individuals is sufficient, but not 
excessive.  A simple statement that the number proposed is required for statistical 
significance is not an adequate response.  Formal power analyses often provide the 
most direct and informative rationale, and are useful in assessing sample sufficiency 
even when numbers are logistically limited by captures, space etc.  See How to do a 
Power Analysis.  If a rationale is based on comparison to prior studies, or specific 
recommendations for a field, provide relevant citations and justify how the current 
design compares to those contexts.  In the case of pilot studies, meaning investigations 
conducted for the express purpose of determining suitable approaches and sample sizes 
for future research, justify your numbers in terms of those objectives. 
 
The sample size for this investigation was based on the experimentation trials for the 
implantation of elastomer tags conducted by Hohn and Petrie-Hanson, specifically Trials 
1-3.(1) Those procedures detailed the use of sample sizes of 10 or 30 zebrafish per replicate 
to ensure proper investigation of a similar surgery, so to reduce the number of animals, this 
proposed experiment will be utilizing 30 zebrafish for each trial as described in 10.a. for 
the observation of immune response and integration. A total of 270 zebrafish will be 
required, as 30 fish per Class D trial  and 30 Class C fish will provide sufficient data to 
establish a typical immune response between replicates while maintaining a survival 
margin to account for possible mortalities or infections to ensure quantifiable data.  A larger 
number of fli1 zebrafish will be utilized for the specific comparison of tissue integration 
between shard shapes, while the MPO fish will be utilized for only one shard shape to 
assess the immune response toward the CNFs. The aforementioned tagging procedure was 
performed and monitored through the juvenile stage, which is in agreement with the 
premise of our implant procedure. 
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c.  Summary:  Provide summary formula(s) that clearly depict how the numbers of 
individuals listed in #8 above are obtained as a product of the number of study 
groups, replicates and sample sizes presented in 10a and 10b. 
 
Class C: 30 juvenile zebrafish = 1 exposure group * 30 individuals per group * 1 age point 
Class D (fli1): 150 juvenile fli1zebrafish = 5 exposure groups (including controls) * 30 
individuals per group * 1 age point 
Class D (MPO): 90 juvenile MPO zebrafish = 3 exposure groups (including controls) * 
30 individuals per group * 1 age point 
 
 
11. Procedures 
 
 The Committee does not wish to receive copies of research proposals or laboratory 
manuals.  The Principal Investigator or Instructor is asked to address succinctly the 
following questions, as applicable.  Special care should be taken to justify any 
procedures generally discouraged by the University's code of ethics and policy. 
 
a. Major categories of procedures.  Please check the appropriate box for EACH 
category. 
Any “yes” responses must be described in sections b. (nonsurgical procedures), 
c. (surgical procedures) or d. (euthanasia) that follow. 
 
Yes No  Categories 
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  1. collection or capture (provide details under section 12) 
  2. nonsurgical marking, tagging, or device attachment 
  3. antibody production:  describe antigen, adjuvant and route of 
immunization 
  4. noninvasive physical or physiological measurements 
  5. dietary manipulations 
  6. pharmacology/toxicology:  material used, route of administration, 
etc. 
  7. blood draw, biopsy or other nonsurgical tissue collection 
  8. behavior studies 
  9. environmental stress, e.g., temperature, restraint, forced exercise 
  10. irradiation:  type, facility to be used 
  11. hazardous materials, e.g., carcinogens, radioactive materials 
  12. biohazardous or infectious agents (use of Class 2 or higher agents 
requires the approval of the University's Biosafety 
Committee). Description must include precautions to restrict 
the spread of biohazardous or infectious agents to non-target 
animals or humans. 
  13. experimental trauma, e.g., planned injury, significant behavioral 
stress 
  14. anesthesia/sedation/immobilization (describe in sections 11 b or 11 
c) 
  15. nonsurvival surgical procedure 
  16. survival surgical procedure (animal is allowed to recover for any 
length of time) 
  17. multiple major operative procedures from which animal is allowed 
to recover 
  18. planned euthanasia (describe method in section 11 d, e.g., harvest 
tissue, necropsy, etc.) 
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  19. other, specify: 
 
 
b. Nonsurgical Procedures (Categories 2-14 and potentially 19): 
 
1. USING THE ABOVE NONSURGICAL CATEGORIES MARKED “YES” AS HEADINGS, 
provide a succinct description of the procedures to be conducted on live vertebrate animals.  
Specify any drug(s), including adjuvants, doses (including frequency) and routes of 
administration.  Specify duration of procedures.  Include any monitoring procedures used 
to ensure effective anesthesia/sedation or recovery from other nonsurgical procedures. 
 
 
4.  Noninvasive physical or physiological measurements: After 3 days post-operation, 
fish will be immobilized with MS-222 (200 mg Tris-buffered tricane 
methanesulfonate/liter), then imaged with fluorescence microscopy and released 
immediately; procedure should take 2-3 minutes. 
 
6. Pharmacology/toxicology: At 24 hpf, embryos will be subjected to a continuous 
treatment of 1-phenyl 2-thiourea (PTU) at a concentration of 11.4mg/L in an egg water 
solution. This treatment will persist for the duration of the experiment, where the solution 
will be changed daily, according to Karlsson, Hofston, and Olsson.(28) 
 
6. Pharmacology/toxicology: Cephalexin and methylene blue will be used as antibiotic and 
antifungal reagents, respectively, directly after the surgery has been performed. 6.6mg/L 
of cephalexin and 30mg/L of methylene blue will be added to the holding tank for 3 days 
post-operation, where the solution will be changed daily. 
 
14. Anesthesia/sedation/immobilization: Fish will be placed in a solution of MS-222 (200 
mg Tris-buffered tricane methanesulfonate/liter) for up to 45 seconds for immobilization 
during implantation and imaging. 
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c. Surgical Procedures (Items 14-17; and potentially 19): 
 
1. USING THE ABOVE SURGICAL CATEGORIES MARKED “YES” AS HEADINGS, provide 
a succinct description of the surgical procedures to be conducted on live vertebrate 
animals. Specify any drug(s), including adjuvants, doses (including frequency) and 
routes of administration.  Specify duration of procedures.  Be sure to include any 
monitoring procedures use to ensure safe and effective anesthesia/sedation. 
 
16. Survival surgical procedure: 
Following anesthesia, an incision of approximately 1mm will be made along the 
dorsal line caudal to the dorsal fin using electrolytically-sharpened tungsten wire, and a 
shard of solid-form nanocellulose will be inserted. The incision will be intramuscular only, 
and the implant will be completely subcutaneous for three-dimensional cellular integration. 
As an alternative that will be determined by the Class C trials, the implant may be injected 
using standard tuberculin syringes, in which case the injury could be further reduced. 
The nanocellulose shards, tungsten wire, and/or the syringe will have been 
sterilized in a solution of 95% ethanol and left to dry under the fume hood prior to the 
surgery. The tungsten wire will be sterilized in 95% ethanol for 30 seconds between each 
fish procedure. Procedure should take up to 1 minute per fish, and incision size is refined 
to minimize affected tissue to reduce the potential of residual pain. No sealant will be used 
on the incision post-implantation as zebrafish skin re-epithelializes within a few hours, 
reducing the chance of environmental contamination.(18) Furthermore, a comparison with 
the negative control and the implant treatments will aid in determining the possibility of 
contamination. 
 
2. Is animal allowed to regain consciousness after surgery? 
Yes. 
 
3. Describe the postsurgical monitoring and care procedures, including what 
response(s) you will look for to indicate recovery or deterioration.  Indicate dosage 
or frequency of any analgesics, other drugs, or pain relieving measures that will be 
used post-operatively. 
 
Postsurgical monitoring will include regular tank maintenance and upkeep for the 
duration of the experiment where behavior/physical appearance of the zebrafish will be 
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observed once daily until feeding age (120 hpf) has been reached, then twice daily for the 
remainder of the experiment, including the post-surgery timeframe of one month. Dead 
fish will be removed to prevent contamination. Upon immediate completion of the surgery, 
stress experienced by the fish will be managed by placing the fish in a dish of egg water to 
regain consciousness, then gently reintroducing the fish to their holding tank to allow 
acclimatization. The holding tank will contain a solution of cephalexin (6.6mg/L) and 
methylene blue (30mg/L) to prevent infection that could interfere alter the response to the 
implant. The zebrafish will be maintained in this antibiotic solution for 3 days post-surgery 
following the protocol by Fang, et. al, then returned to normal holding conditions 
thereafter.(32) 
The physical movement of the fish will be observed post-operation for up to 10 
minutes to ensure that normal behavior is restored. If severe distress is evident from 
unusual behavior (i.e. prolonged erratic swimming, persistent color change indicating 
stress, etc.), the affected fish will be removed from the experiment and promptly euthanized 
as described in 11.d.3. to avoid extended distress. Since the surgical procedure is performed 
only once during the initial portion of the experiment, no other analgesics will be 
administered after the zebrafish have regained consciousness to prevent unnecessary 
deleterious side-effects, such as weakened cardiovascular strength that may lead to death. 
 
 
d. Euthanasia (Category 18 and unplanned euthanasia): 
 
1. Will the animals be killed as part of the study design or at the conclusion of the study? 
 
Yes, at the conclusion of the study. 
 
 
2.* If yes, how will this be accomplished (include dosages/duration if applicable) and 
verified? 
 
The fish will be euthanized with sodium bicarbonate-buffered MS-222 once the 
study has gone to completion.  The zebrafish research community has prepared its own 
detailed user manual that describes the standard procedures used by zebrafish researchers. 
The zebrafish standard operating procedure manual is The Zebrafish Book (1995). The 
Zebrafish Book covers all of the experimental procedures proposed and is available on the 
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internet: go to http://zfin.org/cgi-bin/webdriver?MIval=aa-ZDB_home.apg and choose the 
"The Zebrafish Book" under “News and Information” on the sidebar menu. This procedure 
is planned to be performed only when the experiment is concluded. 
 The animals will be euthanized with an overdose of sodium bicarbonate- buffered 
MS222 (300 mg/L) for a duration of 10 minutes or until the heart has stopped beating. 
 
 
3.* THIS QUESTION MUST BE ANSWERED: If euthanasia becomes necessary due 
to unplanned injury or illness to the animal(s), how will it be accomplished (include 
dosages/duration if applicable) and verified? 
 
 If the animals become injured or sustain an illness, they will be euthanized with an 
overdose of sodium bicarbonate-buffered MS222 (300 mg/L) for a duration of 10 minutes 
or until the heart has stopped beating, as above. 
 
 
*See the 2013 Report of the AVMA Panel on Euthanasia for assistance 
(https://www.avma.org/KB/Policies/Documents/euthanasia.pdf). NOTE:  When possible, 
euthanasia should be conducted in a place or fashion that minimizes the potential for cues 
that could cause distress in other animals (e.g., outside housing room or in an isolated 
chamber or container). 
 
 
12. Animal Sources and Housing 
 
a. Please indicate source of animals.  Note:  The IACUC will approve animal 
purchases from a licensed pet store provided the researcher/instructor informs the 
pet store (in writing) that the purchased animals will be used for research/teaching. 
 
 Purchased or conveyed from a company or other institution 
(please answer the following) 
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1. What are the specific planned commercial or institutional sources? 
 
Zebrafish embryos will be obtained from natural spawnings of adult zebrafish in 
the UMaine fish facility. 
 
 Captured from the wild (please answer the following) 
 
 
1. Where and when will the animals be captured? 
 
2. What specific capture gear will be employed (nets, traps, electrofishing etc.) and 
how will it be operated (e.g., frequency of net or trap checks) 
 
 
3. What steps will be taken to protect animals from exposure or other danger during 
collection? 
 
 
4. Please include your plans for removal of traps, barriers or other gear from the field 
site. 
 
 
5. Indicate if Federal/State permits are required and whether they have been obtained.  
NOTE:  Permit documents must be made available if requested by the IACUC. 
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6.  What precautions will be taken in the field to restrict the spread of pathogens among 
study animals or between study animals and humans? 
 
 
b.   Animal Care/Housing: 
 
IMPORTANT NOTE:  Investigators are expected to follow care and housing guidelines 
outlined in the Guide for the Care and Use of Lab Animals 
(http://grants.nih.gov/grants/olaw/Guide-for-the-Care-and-Use-of-Laboratory-
Animals.pdf) or the Guide for the Care and Use of Agricultural Animals in Agricultural 
Research and Teaching (http://www.fass.org/docs/agguide3rd/Ag_Guide_3rd_ed.pdf) 
unless special exceptions are requested and approved. If specific requirements for your 
animals are not listed in the Guides (e.g. some wildlife), you are expected to adhere to 
recommended practices of the field (e.g., as outlined by professional societies) and known 
biological needs of the species.  All investigators working with housed animals are 
expected to keep records of daily care/feeding, as well as records of other periodic care 
(e.g., grooming, water quality) for inspection by the IACUC. 
 
Will animals be housed or maintained for more than 12 hours? 
 
 Yes 
 No 
 
If yes – answer the following 
 
 
1. Where will the animals be housed and maintained? 
 
They will be housed and maintained in Room 181, Hitchner Hall in the secondary 
zebrafish facility at the University of Maine for the duration of the experiment. 
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2. Does your housing deviate from the requirements of the Guides or recommended 
practices? If so, include a justification for an exception to the Guides for taxa 
covered therein. For taxa not covered by the guides, specify any other guidelines 
you intend to follow, or provide a detailed description of housing and care based 
on your study organism’s known requirements. 
 
No. 
 
3. For genetically modified animals (GMAs – produced via targeted or random 
genetic manipulations), the Guide requires enhanced monitoring and reporting to 
the IACUC.  If this protocol involves GMAs, describe any special care and 
monitoring (including frequency) that will be used to minimize known or unknown 
adverse effects in the genetically altered line. 
 
We will be using the MPO Danio rerio, a transgenic line that expresses GFP on a 
neutrophil-specific myeloperoxidase promoter, where EGFP with an SV40 
polyadenylation site was inserted at the mpo ATG start site.(25) We will also be using the 
transgenic line, fli1 Danio rerio, that expresses EGFP along its vasculature through the use 
of a promoter for fli1.(26) These transgenic lines are both similar to wildtype zebrafish. 
The MPO line was developed specifically for use in immune response studies by Renshaw, 
et.al. at the MRC Centre for Developmental and Biomedical Genetics, University of 
Sheffield, Sheffield UK to provide a more efficient research method for imaging neutrophil 
migration. The fli1 line was developed for observation of blood vessel development in 
zebrafish by Lawson and Weinstein at the Laboratory of Molecular Genetics, NICHD, NIH 
in Bethesda, Maryland.(26) These lines are used throughout the zebrafish community and 
typically require no special care or monitoring; however, for these experiments, animals 
will be examined daily and water will be changed daily to ensure humane treatment.  Adult 
fish have been present in the zebrafish facility for years and are under the direct care and 
supervision of the facility manager. 
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4. Identify the room or facility in which the procedures will be conducted. 
 
All procedures will be conducted in Hitchner Hall. 
 
5. What precautions will be taken to restrict the inadvertent spread of pathogens 
among study animals or between study animals and humans? 
 
Proper PPE procedures will be followed (gloves), and all surfaces will be wiped down with 
ethanol after handling is concluded. 
 
 
13. List all person(s) (including PI) who will handle animals (e.g., carry out the 
procedure(s), animal care, etc.) or provide training of personnel.  For each person 
named below, describe his/her individual experience in performing proposed 
procedures (e.g., years of experience and specific skills); if none, explain how 
training will be obtained.   (NOTE:  to add rows, right-click within table, click on 
“insert” and choose “insert rows above” or “insert rows below”) 
 
 
Personnel  Name Role Years of experience 
Training plan (if no 
experience) 
Dr. Paul Millard PI 
8 years with 
zebrafish (general)  
Dr. Con Sullivan 
Assistant 
Research 
Professor 
12 years with 
zebrafish 
(Innate immunity, 
TNFAIP8 gene 
family, 
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tumorigenesis, tumor 
angiogenesis and 
inflammation) 
Mark Nilan 
Operations 
Manager 
Zebrafish 
maintenance and 
husbandry  
Hanna Anderson 
Student 
Research 
Assistant 
2 years with 
zebrafish 
(microinjections, 
dechorionation, 
general)  
   
 
 
14. If animals will be housed, please list the name, phone number, and email of the 
person who should be contacted to accompany the IACUC during facility 
inspections: 
 
Mark Nilan, 581-3391, Mark.Nilan@umit.maine.edu 
 
15. Have all personnel named above been certified by the IACUC for Responsible Care 
and Use of Animals? 
  Yes      No     A web-based tutorial for this certification is available at:  
http://umaine.edu/research/research-compliance/institutional-animal-care-and-use-
committee-iacuc/web-based-training/.  (Note:  protocol approval will not be granted 
until all personnel have been certified.) 
 
If this is a teaching protocol where students will handle animals as part of course 
participation, please see "Training Requirement for Students Who Handle Live 
Vertebrate Animals in Class." 
 
Indicate which option you will require your class to follow to meet the training 
requirement: 
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 Students will complete the web-based tutorial (referenced above). 
  Students will read the document, “Use of Animals in a Courses:  What You Need 
to Know” (found on the IACUC website under “Training Requirement for 
Students…” as referenced above). 
  Students will be trained by the instructor; attached is a written description 
of the training for IACUC review. 
 
16. Disaster Planning and Emergency Preparedness.  The Guide requires that facilities 
have disaster plans to “define the actions necessary to prevent animal pain, distress, 
and deaths due to loss of systems such as those that control ventilation, cooling, 
heating, or provision of potable water.”  Safety and Environmental Management, 
in conjunction with the IACUC and researchers, are putting disaster plans in place 
that meet University and individual investigator needs, include provisions for triage 
and euthanasia, and provide for training and contact of essential personnel.  Please 
provide the following information: 
 
a. Triage:  Some animals may require priority care (or euthanasia) under a 
facility-wide or campus-wide disaster. For example, they may have greater 
potential to experience severe pain or distress under disruption of services 
(e.g., post-operative individuals) or they may be irreplaceable in a replicate 
study (e.g., novel genetic lines).  Do any animals used in this study require 
special priority for triage?   If so, please describe the basis for this special 
priority and indicate how such animals will be made identifiable within the 
facility (e.g., special marks, lists). 
 
Yes.  The animals used in this study will require special priority for triage 
in the event of a facility-wide or campus-wide disaster.  The animals in this 
study will be clearly marked with red tape or red dots and labeled as 
requiring special priority for triage. 
 
b. Special euthanasia:  Would a different method of euthanasia than that listed 
in section 11.d. be used in the event of a disaster that disrupts normal 
services required for humane care and treatment of these animals?  If yes, 
please describe the special method (include dosing information for 
pharmaceutical approaches). 
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No. 
 
c) Satellite Facility:  If the facility listed under section 12.b.1 is not a “core” 
facility (Aquaculture Research Center, Center for Cooperative Aquaculture 
Research, Small Animal Research Facility, or the Witter Center), the 
facility must have an approved Satellite Facility Designation and Disaster 
Plan (contact the IACUC Office for the form). 
 
 The facility under section 12.b.1 is designated as a ‘core’ facility. 
 
 A Satellite Facility Designation and Disaster Plan has been 
approved for this facility. 
 
 I have attached a completed Satellite Facility Designation and 
Disaster Plan for approval. 
 
 
 
d. Emergency Contact for the Care of Animals: (at least two people must be 
listed): 
 
 
Primary person to contact in case of an emergency = Dr. Paul Millard 
Office phone = 207-581-2265 
Home phone = 207-659-9425 
Cell phone =   207-659-9425 
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Secondary person to contact = Dr. Con Sullivan 
Office phone =207-581-2809 
Home phone =207-884-4911 
  Cell phone = 207-217-7689 
 
 
 
Risk Assessment 
(Risks to researchers) 
 
In compliance with our Public Health Service Animal Welfare Assurance, we have 
implemented an Occupational Health/Medical Surveillance Program.  The first step will 
be for investigators to identify potential hazards with tasks involved with the study, so the 
IACUC veterinarian and Safety and Environmental Management (SEM) can assess the 
risks to determine if further information will be required from everyone named in the 
protocol (i.e., a health questionnaire).  NOTE:  In evaluating this risk assessment 
statement, we will be looking for animal care tasks that increase the risk of illness (such as 
a zoonotic disease), physical injury (such as animal bites), and/or allergic reactions to those 
handling the animals.  Also consider hazards of animal excrement/hazards to workers 
handling the animals’ bedding that may be important to an accurate risk assessment. 
 
Please complete the following for your proposed protocol. 
 
NOTE:  For field studies, the Field Research Hazard Assessment/Safety Plan will be 
helpful in identifying possible risks) 
 
a) Provide a brief description of the protocol (cut and paste response from question 
6 of the protocol).  (NOTE:  Only this page, not the whole protocol, goes to 
SEM and the Occupational Health Physician, thus the request for duplication of 
the answer to question 6.) 
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The main objective of this research project is to utilize the zebrafish animal model 
system to assess biomaterials with potential for use in medical implants.  The biomaterial 
in question is dense nanocellulose in solid form created in the Chemical and Biological 
Engineering Department facilities at the University of Maine. One aspect of the project 
will focus on methods for implanting the novel nanocellulose material into zebrafish to 
evaluate the potential of this material for use in prosthetics in humans, as zebrafish contain 
a similar. This project holds considerable potential for the advancement of naturally-
sourced implantable biomaterials due to the biocompatibility, durability, and availability 
of nanocellulose. With a porous composition, nanocellulose enables ample cellular 
integration, permitting a more secure implant. Variations in structure, including the density 
and specific shape of the nanocellulose shard, affect the integration into tissues, therefore 
optimization of these parameters is crucial for the improvement of existing implant 
formats. Implantation will likely require micro-incisions to be made on the model, and/or 
physical modification of the nanocellulose to permit insertion. A new approach for creating 
micro-incisions in the zebrafish may need to be developed, as zebrafish are delicate and 
are only a few millimeters in length, rendering conventional techniques difficult to 
implement while maintaining the survival of the animal. 
When implantation has been accomplished, immune responses and other changes 
in the condition of surrounding tissue will be monitored and recorded by imaging, 
including bright-field and fluorescence microscopy.  GFP-tagged zebrafish will be utilized 
for the visualization and quantification of neutrophils migrating to the site of implantation. 
The amount of neutrophils that migrate will indicate whether the nanocellulose has been 
rejected or accepted by the model, providing insight into whether it remains inert when 
introduced to tissue. The observation of cellular integration of the nanocellulose in the 
model will also be conducted through the use of fli1 zebrafish (GFP-labeled vasculature), 
as well as the microscopy methods listed above. 
 
 
b) List the tasks required.  (Examples:  handling animals, administering drugs, 
euthanasia; field work could include driving, operating watercraft.) 
 
1. Continuous administration of 1-phenyl 2-thiourea (PTU) in holding tanks 
2. Obtainment of nanocellulose shards 
3. Sterilization of shards and tungsten wire in 95% ethanol 
4. Performing microincisions on zebrafish 
5. Implantation of nanocellulose into model 
6. Using cephalexin monohydrate (capsule form) and methylene blue (capsule 
form) for post-surgical treatment of fish 
7. Monitor fish through confocal and fluorescence microscopy 
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c) For each of the tasks described in b) above, list the associated hazards.  (Examples; 
exposure to allergens, needle stick.) 
 
1. Fatal if swallowed, may cause allergic skin reaction 
2. Accidental puncture from shards, respiratory exposure 
3. Exposure to ethanol, accidental puncture from shards or tungsten wire, 
respiratory 
     exposure 
4. Sharpened tungsten wire, accidental puncture 
5. Accidental puncture from shards, respiratory exposure 
6. Cephalexin monohydrate: May cause an allergic skin reaction, may cause 
allergy or 
    asthma symptoms or breathing difficulties if inhaled; Methylene blue: ingestion 
7. Exposure to fixatives, methanol, and other chemicals; laser 
d) For each of the hazards described in c) above list how the hazards will be managed.  
(Examples: use of gloves and goggles, field work training.) 
 
1. Appropriate PPE (gloves, safety goggles, lab coat) and disposal of materials 
(biohazard 
bags); avoid breathing in, contaminated work clothing should not be 
allowed out of the workplace; Wash face, hands and any exposed skin 
thoroughly after handling, do not eat, drink or smoke when using. 
2. Work in cell culture hood.  Appropriate PPE (gloves, safety goggles, lab coat) 
and 
disposal of materials (biohazard bags); treat area as standard for puncture 
injuries (wash with soap and water and watch for signs of infection), work 
under fume hood to meet exposure limits: OSHA permissible exposure limit 
(PEL) 15mg/m3 total dust, 5 mg/m3 respirable fraction for nuisance dusts. 
3. Appropriate PPE (gloves, safety goggles, lab coat) and disposal of materials 
(biohazard bags); avoid inhalation or eye contact with ethanol; treat area as 
standard for puncture injuries (wash with soap and water and watch for 
signs of infection), work under fume hood to meet exposure limits: OSHA 
permissible exposure limit (PEL) 15mg/m3 total dust, 5 mg/m3 respirable 
fraction for nuisance dusts. 
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4. Appropriate PPE (gloves, safety goggles, lab coat) and disposal of materials 
(biohazard bags); treat area as standard for puncture injuries (wash with 
soap and water and watch for signs of infection) 
5. Appropriate PPE (gloves, safety goggles, lab coat) and disposal of materials 
(biohazard bags); treat area as standard for puncture injuries (wash with 
soap and water and watch for signs of infection), work under fume hood to 
meet exposure limits: OSHA permissible exposure limit (PEL) 15mg/m3 
total dust, 5 mg/m3 respirable fraction for nuisance dusts. 
6. Appropriate PPE (gloves, safety goggles, lab coat) and disposal of materials 
(biohazard 
bags); Use outdoors or in a well-ventilated area, modify administration 
method by opening the capsule underwater to prevent airborne material; 
Wash face, hands and any exposed skin thoroughly after handling, do not 
eat, drink or smoke when using. 
7.  Appropriate PPE (gloves, safety goggles, lab coat) and disposal of materials 
(biohazard bags); Restricted access with appropriate signage.  Avoid direct 
eye contact. 
 
After this risk assessment is reviewed, everyone named in the protocol may be 
required to complete a health questionnaire.  The health questionnaire may require 
review by the Occupational Health Physician.  If so, there is a charge for this review 
(~$45).  Researchers are asked to budget for these costs in proposals for outside 
funding.  For unfunded studies, the cost will be covered by the Office of the Vice 
President for Research.      If you have any questions regarding the completion of this 
page, please contact, Safety and Environmental Management (SEM), 1-4055. 
 
 
 
 
SEARCH FOR ALTERNATIVES TO PAINFUL/DISTRESSFUL PROCEDURES 
 
 
This form must be completed if the pain classification from Question #8 was D or E 
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Please read the background information on the USDA policy for painful and distressful 
procedures before completing this form (Appendix 1). 
 
The written narrative should include adequate information for the IACUC to assess that a 
reasonable and good faith effort was made to determine the availability of alternatives or 
alternative methods. 
 
 
The following information is required: 
 
1) The names(s) of the database(s) searched (due to the variation in subject 
coverage and sources used, one database is seldom adequate); 
 
ALTBIB 
PubMed 
ScienceDirect (Elsevier) 
Google Scholar 
 
2) The date the search was performed. 
 
4/13/2017 
 
3) The time period covered by the search. 
 
2000-2017 
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4) The search strategy (including scientifically relevant terminology) used. 
 
A terminology search was conducted across the databases listed above, 
including the terms: zebrafish incision method, zebrafish implant, zebrafish 
surgery, zebrafish tissue injury, zebrafish immune response, analgesics 
zebrafish, Danio rerio incision, Danio rerio implant. 
 
5) Did your database search (or other source) identify a bona fide alternative 
method (one that could be used to accomplish the goals of the animal use 
proposed)? 
 
No. 
 
 
If yes, please explain why the alternative found was not proposed.  (NOTE:  The 
IACUC will consider this explanation, but may determine it is not adequate 
to justify not using the bona fide alternative. 
 
If no, the IACUC would like a description of the results of the database search (or 
other source) to document the lack of relevant alternatives. 
 
This database search produced minimal results for implantation 
studies of this exact nature, but a combination of related investigations 
utilizing zebrafish yielded methods of comparable pain management. When 
delving into methods of more serious operations with alternative target 
results, the anesthesia procedures were similar to that which is proposed 
here: immersion in a MS-222 solution (200 mg Tris-buffered tricaine 
methanesulfonate/liter). For example, Richardson, et. al. conducted a study 
to assess the immune response of zebrafish when a tissue wound was 
inflicted, and examination of the procedure indicated the use of a 0.13% 
tricaine solution (MS-222) for the anesthetic, as well as the addition of a 
hydrocortisone or sodium warfarin treatment to the tank water prior to the 
operation.(18) The injury involved in this citation was created for the 
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observation of the regeneration of epithelial cells and the inflammation 
response at the site of affectation, therefore a large excision was created in 
the zebrafish tissue. A dermal laser was employed, as well as multiple 
treatments of heat-shocking. Another study, conducted by Peng, et.al., 
described the observation of spinal cord regeneration in zebrafish, where, 
after anesthetizing the fish in a solution of MS-222, an incision was made 
to access and cut the spinal cord.(38) 
Our proposed experiment will consist of an incision in the tissue, 
and in contrast to the studies above, no tissue will be removed nor will the 
incision be deep enough to expose the spinal cord during the process of 
injury. The implant will be inserted completely subcutaneously within the 
intramuscular space. This is to allow a more rapid recovery and to decrease 
the wound size, reducing the amount of pain that will be experienced. Due 
to this parameter, our experiment is expected to inflict less pain than that of 
the Richardson, et. al. and the Peng, et.al. studies, therefore the treatments 
we have listed will be suitable for the assurance of complete anesthetization 
and pain management. 
There have also been studies conducted that explore the use of post-
operational analgesics, including the addition of isoflurane or lidocaine 
hydrochloride to the MS-222 solution to decrease potential side effects of 
MS-222 and to increase recovery time.(39,40) For this proposed 
experiment, the main focus is the examination of the natural immune 
reaction to the implant, therefore an induced recovery time may not provide 
accurate results of the neutrophil migration. Furthermore, in a microbead 
implantation procedure detailed by Gerlach et. al., as well as in a separate 
elastomer tagging procedure by Hohn and Petrie-Lanson, no additional 
analgesics were applied to the zebrafish after development into the juvenile 
and adult stages later in the experiments.(16,37) Therefore, it has been 
concluded that the proposed experiment does not have a bona fide 
alternative method through which to proceed, and that the methods 
proposed here are of comparable or refined pain management. 
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ASSURANCES FOR THE HUMANE CARE AND USE OF ANIMALS 
 
As the Principal Investigator on this protocol, I assure that… 
1) I have provided an accurate description of the animal care and use protocol to be 
followed in the proposed project/course. 
2) the activities proposed do not unnecessarily duplicate previous experiments. 
3) all individuals named in this application who are at risk will be registered in the 
Occupational Health and Safety Program. 
4) all individuals performing animal procedures described in this application are 
technically competent and have been (or will be) properly trained in the procedures 
to ensure that no unnecessary pain or distress will be caused as a result of the 
procedures. 
5) I will obtain approval from the IACUC before initiating any changes to this 
protocol. 
6) I am familiar with and will comply with the University of Maine’s Policies and 
Procedures for the Humane Care and Use of Animals, and I assume responsibility 
for compliance by all personnel involved with this protocol. 
7) I have read and will follow the appropriate guidelines for the proposed species. 
8) if using laboratory animals, all personnel handling the animals have had a tetanus 
shot within the past ten years. 
9) all applicable rules and regulations regarding radiation protection, biosafety, 
recombinant issues, hazardous chemicals, etc., have been addressed in the 
preparation of this application and the appropriate reviews have been initiated. 
10) animals will be purchased only from licensed, reputable vendors.  If animals are 
purchased form a pet store, the pet store has been informed (in writing) that the 
animals will be used for research or teaching purposes. 
11) I will maintain appropriate animal records (e.g., census, health, veterinary care, 
euthanasia, surgery, diagnostic, anesthesia, etc.) 
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12) I will report at once to the IACUC any unanticipated harm to animals. 
13) I acknowledge that in the event of a disaster (natural or man-made) it may become 
necessary to triage, euthanize or otherwise modify the care and disposition of the 
study animals in order to avoid unacceptable pain or distress.  I delegate overriding 
authority for emergency decisions of animal disposition to the Institutional 
Veterinarian or his/her designated representative. 
 
Submission of the protocol indicates you have read and agree to the above Assurances 
 
REMINDER:  The Principal Investigator (PI) MUST submit the protocol.  Another faculty 
member (no students) may submit the protocol on behalf of the PI with documentation of an 
email exchange that the PI has read and approves.  We require this because the PI is ultimately 
responsible for the content of the protocol submission.  
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